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Dopamine transporter (DAT) controls dopamine (DA) neurotransmission by clearing 
synaptically released DA. The substrate uptake function of DAT is regulated by its subcellular 
localization. We propose that DAT localization and trafficking are regulated by its molecular 
conformation and interactions of the transporter with lipids and membrane-associated proteins. 
We used several experimental approaches and two DAT mutants to demonstrate that 
accumulation of DAT in plasma membrane protrusions, such as myosin X-dependent filopodia, 
requires an outward facing (OF) conformation of the DAT molecule. Furthermore, using targeted 
plasma membrane depletion of phosphatidylinositol 4,5-bisphosphate (PIP2), a lipid that is 
highly enriched in the plasma membrane and proposed to bind DAT, we demonstrated that PIP2 
is necessary for protein kinase C (PKC)-stimulated DAT endocytosis but not essential for 
maintaining steady-state levels of DAT at the cell surface. Therefore, these results suggest that 
PIP2 is essential for clathrin-mediated PKC-stimulated DAT endocytosis and PIP2 is not involved 
in the retention of DAT at the cell surface. In search of DAT interactors regulating its plasma 
membrane retention, distribution, subcellular localization, and function, we used quantitative 
mass spectrometry analysis to identify proteins that are co-precipitated with DAT isolated from 
the mouse striatum. A novel interaction of DAT with Gαo, the α subunit of Go proteins that are 
coupled to dopamine D2 receptor and other receptors, was confirmed by reciprocal co-
immunoprecipitation and western blotting in mouse striatum and a heterologous expression 
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system. While structure-functional analysis of this interaction will be performed in the future 
studies, our biochemical and morphological analyses led to the hypothesis that DAT-Gαo 
interaction may mediate the regulatory effects of D2 auto-receptors on DAT localization and 
activity. In summary, our data suggest that the localization of DAT in filopodia, which is 
regulated by DAT conformation and possibly DAT-Gαo interaction but not DAT interaction 
with PIP2, is the primary mechanisms of the retention of functional DAT at the cell surface. 
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1.0  INTRODUCTION 
1.1 THE DOPAMINE SYSTEM 
Dopamine (DA) is an essential neurotransmitter in the mammalian central nervous system 
(CNS); it is involved in reward-motivated behavior, motor control, cognitive capacities 
development, and attention regulation (Nieoullon 2002, Schultz 2002). Dysfunction of the 
dopaminergic system is involved in neuronal pathologies such as Parkinson’s disease, 
schizophrenia, bipolar disorder, attention deficit hyperactivity disorder (ADHD), and 
psychostimulant drug abuse (Volkow et al 2009).  
The somas of dopaminergic neurons are mainly located in the midbrain. There are four 
predominant dopaminergic pathways (Figure 1.1). In the nigro-striatal pathway, dopaminergic 
neurons in the substantia nigra pars compacta (SNc) project to the dorsal striatum (composed of 
caudate nucleus and putamen). The nigro-striatal pathway plays an important role in motor 
control. Degeneration of nigro-striatal dopaminergic neurons results in Parkinson’s disease 
(Christine & Aminoff 2004). Dopaminergic neurons in both the mesolimbic pathway and the 
mesocortical pathway originate from the ventral tegmental area (VTA). Mesolimbic 
dopaminergic neurons project mainly to the nucleus accumbens (NAc). In the mesocortical 
pathway, dopaminergic neurons project to the olfactory bulb, the amygdala, the hippocampus, 
the orbital and medial prefrontal cortex, and the cingulate gyrus. The mesolimbic pathway 
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mediates pleasure in the brain, and functions in emotion and reward systems (Björklund & 
Dunnett 2007). The mesolimbic pathway can be plastically changed by drugs of abuse, and plays 
an important role in the development of drug addiction. Dysfunction in the mesolimbic pathway 
is also associated with schizophrenia, bipolar depression, and learning deficits. The mesocortical 
pathway regulates cognitive functions including motivation, reward, emotion, and impulse 
control, and is involved in cognitive and emotional diseases such as schizophrenia and ADHD 
(Björklund & Dunnett 2007). In the tuberoinfundibular pathway, dopaminergic neurons in the 
arcuate nucleus of the hypothalamus project to the pituitary gland. The function of DA released 
in the tuberoinfundibular pathway is to inhibit prolactin release (Ben-Jonathan & Hnasko 2001). 
There are interactions between DA and other neurotransmitters such as γ-aminobutyric 
acid (GABA). For example, the VTA-to-NAc pathway contains parallel dopaminergic and 
GABAergic projections that are often co-activated by reward stimulation (Steffensen et al 1998). 
DA released in the synapse induces inhibition of presynaptic GABA release via dopamine 
receptors in the presynaptic GABAergic neurons (Ishikawa et al 2013). Extra DA released in the 
mesolimbic pathway also causes the generation of silent glutamatergic synapses in which the N-
methyl-D-aspartic acid receptor (NMDAR)-mediated excitatory postsynaptic currents (EPSCs) 
are relatively stable and α-amino-3-hydroxymethyl-4-isoxazolepropionic acid receptor 
(AMPAR) currents are minimal. In the NAc shell, exposure to cocaine generates silent 
glutamatergic synapses that are formed by membrane insertion of new NMDARs (Huang et al 
2009). 
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Figure 1.1. Major dopaminergic pathways in the CNS (Scarr et al 2013). 
DA is synthesized from tyrosine in the cytoplasm of dopaminergic neurons. Tyrosine 
hydroxylase (TH) converts tyrosine to L-DOPA, which is the rate-limiting step in DA synthesis. 
L-DOPA is rapidly converted to DA by aromatic amino acid decarboxylase. DA is released into 
the synaptic cleft through vesicle exocytosis upon dopaminergic neuron activation. Extracellular 
DA is cleared by the dopamine transporter (DAT) expressed in dopaminergic neurons (Amara & 
Kuhar 1993, Giros et al 1996) and can also be metabolized by the catechol-O-methyl transferase 
(Diego et al 2012).  
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The five subtypes of DA receptors (D1-D5) are members of the G-protein-coupled 
receptor (GPCR) superfamily. They are divided into two major subclasses. The D1-like receptors 
(D1 and D5) are coupled to Gs proteins and stimulate signal transduction through activating 
cyclic adenosine monophosphate (cAMP) formation. D2-like receptors (D2, D3 and D4) are 
coupled to Gi/o proteins and exert the opposite effect on cAMP level (Seeman 2010). Both D1 
and D2 receptors are located in the NAc and dorsal striatum (Girault & Greengard 2004). D1 and 
D2 receptors are the most abundant DA receptors in human CNS, while the other three receptors 
are expressed at significantly lower levels. D1 and D5 receptors are mostly involved in 
postsynaptic signal transduction, whereas D2, D3 and D4 receptors are involved in both pre- and 
postsynaptic signal transduction (Seeman 2010). There are two forms of D2 receptors, short form 
(D2SR) and long form (D2LR). D2SR is predominantly located on the presynaptic membrane 
and functions as an auto-receptor (Khan et al 1998). The D2 auto-receptor senses DA level in the 
synaptic cleft and regulates extracellular DA by modulating DA synthesis, DA vesicle 
exocytosis, and the function of DAT (Bello et al 2011, Dickinson et al 1999, Ford 2014).  
1.2 DOPAMINE TRANSPORTER (DAT) – STRUCTURE, FUNCTION AND 
LOCALIZATION 
Synaptically-released DA is primarily cleared from extraneuronal space by DAT (Amara & 
Kuhar 1993, Giros et al 1996). The rate of DA clearance by DAT controls the duration and 
amplitude of post-synaptic DA signaling. DAT is exclusively expressed in dopaminergic 
neurons. The highest density of DAT is observed in the presynaptic surface of axons in the 
dorsal striatum and the NAc (Block et al 2015, Ciliax et al 1999). 
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DAT belongs to the high-affinity, sodium- and chloride- dependent SLC6 transporter 
gene family, which also includes serotonin, norepinephrine, glycine, and GABA neurotransmitter 
transporters (Gether et al 2006). Like other members of the family, DAT consists of intracellular 
amino- (N-) and carboxyl- (C-) termini, and 12 transmembrane helical segments (TM), with 
TM1-5 and TM6-10 forming pseudo-symmetrically inverted repeats (Penmatsa et al 2013). A 
centrally located high-affinity primary substrate-binding site (S1) lined by TM1, 3, 6 and 8 binds 
the substrate (DA) and ions, before their translocation and release to the cytoplasm. Helices TM1 
and TM6 are broken into two segments each, TM1a, TM1b, TM6a, and TM6b, near the DA/ions 
binding site. Another substrate-binding site (S2) is located closer to the extracellular (EC) 
vestibule of DAT and formed by residues from TM1, 3, 10, and extracellular loops (EL) 2 and 4 
(Shan et al 2011). DA uptake by DAT requires the co-transport of two sodium ions and one 
chloride ion driven by the electrochemical gradients of these ions (Sonders et al 1997). 
A multitude of substrates and inhibitors have been shown to bind DAT. Besides DA, 
norepinephrine and amphetamines (AMPHs) can be transported by DAT (Sulzer 2011). 
Conversely, DA is the substrate of the norepinephrine transporter. Cocaine and its derivatives are 
the best-studied competitive inhibitors of DAT. Cocaine binds with high affinity to the S1 site in 
the extracellular vestibule of DAT, thus blocking the binding and transport of DA. 
It has been proposed that DAT conformation dynamically shifts between outward-facing 
(OF) and inward-facing (IF) states during the transport cycle (Figure 1.2) (Shan et al 2011, 
Yamashita et al 2005). Substrate binding in the OF conformation of DAT (red) promotes the 
formation of an occluded conformation (orange). The binding of a second substrate (doubly 
occupied state in green) induces conformational changes in the S1 site and the intracellular side 
through conserved interaction networks (colored lozenges) positioned between the S2 and S1 
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sites, which reorganize the interaction network at the intracellular end, eventually leading to the 
release of substrate in the S1 site from the IF conformation (cyan). Inhibitors that bind the 
substrate binding sites block the transition of DAT from OF state to IF state. 
An intracellular (IC) interaction network involving TM1a, TM5, TM6b, TM8, and the N-
terminal segment (amino acids, a.a. 1-65) has been found to play a role in regulating the 
conformational transitions in DAT (Cheng & Bahar 2015, Khelashvili et al 2015, Loland et al 
2004). In particular, the closure of the IC vestibule in the OF state of DAT is stabilized by the 
salt bridge between R60 (N-terminus) and D436 (TM8) and the tri-aromatic interaction of W63 
(N-terminus), F332 (TM6b) and Y335 (TM6b) (Cheng & Bahar 2015, Khelashvili et al 2015, 
Loland et al 2004). Disruption of this IC interaction network was observed to facilitate the 
structural transition from OF state to IF state in DAT (Cheng & Bahar 2015) and in its structural 
homolog, the leucine transporter (LeuT) (Cheng & Bahar 2014). Mutations of IC networking 
residues have been predicted to shift the conformational equilibrium toward the IF state 
(Kniazeff et al 2008), in which the EC vestibule becomes less accessible (to the EC environment) 
than does the IC vestibule (to the cytoplasmic environment).  
It has been demonstrated that binding substrates such as DA and AMPH drives a 
structural transition toward the IF state of DAT (Cheng & Bahar 2015, Cheng et al 2015, 
Khelashvili et al 2015, Shan et al 2011), while inhibitors such as cocaine stabilize DAT in the 
OF state (Chen et al 2000, Dehnes et al 2014) through competitive binding to the S1 site 
(Beuming et al 2008, Cheng et al 2015, Wang et al 2015). During the binding of DA or other 
substrates, it is necessary for DAT to be in the OF state, and then transit to the IF state when the 
substrates are taken up (Figure 1.2). Similarly, the serotonin transporter (SERT) is proposed to 
exhibit the same alteration between outward- and inward-facing states, driven by substrates and 
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inhibitors (Zhang et al 2016). The OF conformation of SERT can be stabilized by cocaine, and 
the IF state of SERT can be induced by its substrates such as serotonin. 
 
Figure 1.2. Cartoon model of substrate-induced transition of DAT conformation (Shan et al 2011). 
Palmitoylation and lipids/ions binding may stabilize the structure of DAT. DAT has also 
been shown to be palmitylated via a thioester bond connected to a cysteine residue (C580) at the 
plasma membrane. Inhibition of DAT palmitoylation results in decreased DA uptake activity of 
DAT (Rastedt et al 2017). The X-ray structure of DAT reveals a cholesterol molecule that is 
located in a groove between TM5 and TM7 (Penmatsa et al 2013). It has been suggested that the 
binding of cholesterol helps to stabilize the OF conformation of DAT (Hong & Amara 2010). 
Besides, zinc ion binds four extracellular residues of DAT and stabilizes its OF conformation 
(Stockner et al 2013). 
Another DAT substrate, AMPH, activates calcium/calmodulin-dependent protein kinase 
II (CaMKII) through the mechanisms independent of the transport through DAT. CaMKII is 
proposed to phosphorylate the N-terminus of DAT. The phosphorylation of the N-terminus 
results in the reverse substrate transport activity of DAT (efflux) and has been attributed to a 
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shift in the equilibrium distribution of DAT conformation towards its IF state (Cheng et al 2015, 
Fog et al 2006, Guptaroy et al 2011). Phosphorylated DAT in cells treated with AMPH, 
functions as a channel and mediates constitutive DA release from the cytoplasm without the 
coupling to sodium or chloride ions (Sonders et al 1997).  
1.3 DAT SUBCELLULAR LOCALIZATION, TRAFFICKING AND ENDOCYTOSIS 
1.3.1 DAT synthesis and trafficking 
DAT is synthesized at the endoplasmic reticulum (ER) membrane of dopaminergic neurons that 
is localized in the neuronal soma (Hoffman et al 1998, Turiault et al 2007). Vesicles containing 
newly synthesized DAT molecules leave the rough ER membrane and fuse with the cis face of 
the Golgi apparatus. DAT undergoes N-linked glycosylation in the ER and the Golgi apparatus. 
DAT then traffics in vesicles from the trans-Golgi network (TGN) to the plasma membrane 
(Hersch et al 1997). N-glycosylation is critical for the efficient trafficking of newly synthesized 
DAT to the plasma membrane as well as for the proper DA uptake activity of DAT (Li et al 
2004). The DAT C-terminus is important for the ER export of DAT. Mutation of DAT C-
terminal residues such as Lys-590, Asp-600 or Gly-585 to alanine results in the retention of DAT 
in the ER (Miranda et al 2004). Deletion of the last three residues (PDZ binding motif) in the 
DAT C-terminus (LKV) also results in insufficient plasma membrane delivery of newly 
synthesized DAT (Bjerggaard et al 2004). DAT oligomers are formed in the ER and maintained 
in the trafficking system and the plasma membrane (Sorkina et al 2003). The oligomerization of 
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DAT is necessary for proper DAT trafficking from the ER to the plasma membrane (Sorkina et 
al 2003, Torres et al 2003). 
1.3.2 DAT at the cell surface: subdomain distribution 
DAT is found in the plasma membrane of the soma, dendrites, and axons of dopaminergic 
neurons, and DAT is especially enriched in the membrane of the axons in the striatum (Block et 
al 2015, Nirenberg et al 1996). However, mechanisms controlling this distribution are unknown. 
Besides, DAT is found to accumulate in the filopodia-like membrane protrusions in cultured 
postnatal dopaminergic neurons and brain striatum slices. DAT displays normal (characteristic of 
a typical membrane protein) distribution in the plasma membrane of cultured dopaminergic 
neurons, although DAT is significantly less mobile in the filopodia (Eriksen et al 2009, Rao et al 
2012). The mechanisms underlying high fraction of immobile DAT in filopodia are unclear, and 
the mechanisms of DAT targeting to filopodia are unknown.   
Membrane lipids also regulate the distribution of DAT in the plasma membrane. DAT 
was shown to partially localize to cholesterol-rich membrane rafts in the plasma membrane 
(Foster et al 2008). Furthermore, the uptake activity of DAT is decreased by methyl-β-
cyclodextrin (mβCD), which extracts cholesterol from membranes and disrups lipid rafts 
(Kabouridis et al 2000). A membrane raft protein flotillin-1 (Flot1) has been shown to regulate 
DAT membrane mobility and facilitate AMPH-induced DAT-dependent drosophila 
hyperlocomotion (Pizzo et al 2013, Sorkina et al 2013). The N-terminus of DAT interacts with 
Phosphatidylinositol (4,5)-bisphosphate (PIP2), an important membrane lipids that regulates the 
function of many ion channels, receptors, and transporters (Hamilton et al 2014). It has been 
demonstrated that the mutation of PIP2 binding sites in DAT (K3/K5) to alanine (K3A/K5A) 
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reduces the effect of AMPH-induced DAT-mediated psychomotor behaviors in drosophila. It has 
been proposed that the DAT-PIP2 interaction may serve as part of the mechanism for the 
retention of DAT from endocytosis in the plasma membrane (Fagan et al 2015).  
1.3.3 Endocytosis 
Endocytosis is the process by which cells internalize membrane molecules by engulfing them 
with the cell membrane. Endocytosis and post-endocytic trafficking regulate the surface 
expression of many plasma membrane receptors, transporters, and ion channels. The best-
understood endocytosis pathway is clathrin-mediated endocytosis (CME) (Kirchhausen et al 
2014). CME begins with the assembly of clathrin, cargo molecules, the adaptor complex AP-2, 
and other clathrin-associated proteins into clathrin-coated pits (CCPs) on the inner surface of the 
plasma membrane. CCPs bud into the cell and form clathrin-coated vesicles (CCVs). The 
scission of newly formed CCVs from the plasma membrane requires the GTPase dynamin.  
There are other endocytic pathways that occur in the absence of clathrin. The small-scale 
(<200 nm vesicle) clathrin-independent endocytosis (CIE) pathways can be classified as 
dynamin-dependent and dynamin-independent pathways (Mayor et al 2014). Dynamin-
dependent CIE pathways include caveolin-dependent endocytosis, RhoA-dependent endocytosis, 
and endophilin-mediated endocytosis (Boucrot et al 2015). Dynamin-independent CIE pathways 
include the endocytosis of GPI-AP enriched early endosomal compartments (GEECs) mediated 
by clathrin-independent carriers (CLICs) (CG pathway), Arf6-dependent endocytosis, and 
flotillin-dependent endocytosis. Overall, mechanisms of clathrin-independent endocytosis are 
poorly understood. 
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The endocytic trafficking itinerary is schematically shown in Figure 1.3. Membrane 
cargos can be endocytosed by clathrin-dependent, caveolin-dependent, or other mechanisms that 
are dependent or independent of dynamin. Both CCVs and non-clathrin coated vesicles that bud 
from the plasma membrane are fused with early endosomes (EEs), tubular-vesicular 
compartments with heterologous morphology (Sorkin & Puthenveedu 2013). The vacuolar 
domain of an EE is often termed a sorting endosome (SE), in which endocytosed cargos are 
sorted for recycling or degradation. The extending tubule of an EE is a recycling endosome (RE) 
that can detach from a SE, forming peripherally a RE or a peri-centriolar endosomal recycling 
compartment (ERC). Cargos destined for recycling to the plasma membrane are packaged into 
recycling carriers (typically tubules) that budded from the SE-attached REs (fast-recycling 
pathway) or vesicles budded from the ERCs or peripheral REs (slow-recycling pathway) 
(Klumperman & Raposo 2014). SEs undergo fusion and maturation after cargo destined for 
recycling is left, leading to formation of late endosomes (LEs). SE and LE often display a 
morphology of multivesicular bodies (MVBs), endosomes containing intraluminal vesicles 
(ILVs). Cargos destined for degradation are accumulated in ILVs and thus sequestered from 
recycling. LEs fuse with primary lysosomes (LYSs), where enzymes degrade ILVs and their 
cargos (Seaman 2008). The pH level decreases from EE (6.2-6.3) to LE (5.2-5.8) (Yamashiro & 
Maxfield 1987).   
Small monomeric Ras-like GTPases of the Rab family play a crucial role in regulating 
endosome tethering and fusion, maturation and sorting processes (Grosshans et al 2006). 
Because of the specificity of individual Rab GTPases for various types of endosomes and other 
membrane compartments, Rabs have been widely used as markers of these compartments. For 
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example, Rab5 is predominantly localized to EEs, Rab11 to ERCs and peripheral REs, and Rab7 
to LEs.  
 
Figure 1.3. Pathways of endocytic trafficking. 
1.3.4 Constitutive and stimulated DAT endocytosis 
Endocytosis may regulate the surface expression level of DAT, and therefore regulates the Vmax 
of DA uptake activity. DAT is proposed to constitutively internalize from the plasma membrane. 
DAT endocytosis is stimulated by protein kinase C (PKC), substrates such as DA and AMPH, 
glial cell-derived neurotrophic factor (GDNF), and the inhibition of activated by cdc42 kinase 1 
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(Ack1) (Chi & Reith 2003, Richardson et al 2016, Wu et al 2015, Zahniser & Sorkin 2009, Zhu 
et al 2015). PKC- and AMPH-stimulated DAT endocytosis are the best studied.  
Constitutive endocytosis of DAT has been observed in the soma and synaptic varicosity 
of cultured dopaminergic neurons using fluorescent cocaine analog JHC1-64 that binds to DAT 
with high affinity (Eriksen et al 2009). A pool of DAT has been found in EEs, REs and LEs 
(Eriksen et al 2010). Using knock-in mice expressing HA-DAT, it has been demonstrated that a 
small pool of HA-DAT is internalized into EEs and REs in the varicosities of cultured 
dopaminergic neurons that also contain synaptic markers (Rao et al 2012). By contrast, in acute 
sagittal brain slices and intact animals, endosomes containing DAT are virtually absent in axons 
and synapses of dopaminergic neurons in the striatum, while DAT is presented in EEs, REs and a 
small fraction of LEs and LYSs in the somatodendritic regions of dopaminergic neurons (Block 
et al 2015). The latter study proposes that constitutive DAT endocytosis is negligible in the 
axonal domain. Other groups have used biochemical techniques, such as biotinylation, to 
demonstrate DAT endocytosis in striatum (Gabriel et al 2013). Unfortunately, up to date, 
significant concentration of DAT in endosomes has not been directly demonstrated by optical 
methods.  
It has been demonstrated that constitutive DAT endocytosis is dynamin-dependent in 
dopaminergic neurons (Eriksen et al 2009). Our laboratory has also shown that constitutive DAT 
endocytosis is both clathrin- and dynamin- dependent in PAE cells using siRNA knockdown of 
clathrin/dynamin and biotinylation (Sorkina et al 2005). However, other research groups have 
reported that constitutive DAT endocytosis is dynamin-independent in brain slices and the 
heterologous SK-N-MC cells using biotinylation, whereas the recycling of DAT to the plasma 
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membrane requires dynamin (Gabriel et al 2013). Additional experiments using more sensitive 
methods and more effective ways of depleting clathrin are necessary to reconcile these results.  
Based on current findings, we propose that most constitutive DAT endocytosis occurs in 
the cell body and axon varicosities of dopaminergic neurons, and there is limited DAT cycling 
between surface and RE in synapses (Figure 1.4). DAT is synthesized in the cytoplasm of 
dopaminergic neurons and transported to the plasma membrane through the endoplasmic 
reticulum (ER) and Golgi apparatus. In the somatodendritic region of a dopaminergic neuron, 
DAT is constitutively internalized through conventional CME or dynamin-dependent CIE 
pathways. DAT-containing endocytic vesicles (EVs) fuse with EEs, where DAT is sorted for 
recycling (to recycling endosomes, REs) or degradation (to late endosomes, LEs, and then to 
lysosomes, LYSs). DAT travels from the soma to the dendrites and axons of dopaminergic 
neuron through either vesicular transport or lateral membrane diffusion. Axons contain numerous 
synaptic areas (varicosities) where DA in synaptic vesicles (SVs) is released. DAT endocytosis 
in a varicosity probably involves rapid cycling between the plasma membrane and EE/RE. DA 
released in the synaptic cleft binds postsynaptic dopamine receptors such as D1 receptor (D1R) 
and the long form of D2 receptor (D2LR), and is mainly cleared by DAT in the presynaptic 
membrane. 
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Figure 1.4. Hypothetical model of DAT trafficking in dopaminergic neurons. 
PKC activation induced by phorbol 12-myristate 13-acetate (PMA) acutely down-
regulates surface DAT by rapidly increasing basal endocytic rates and slowing surface delivery, 
which is widely demonstrated in heterologously expressing cells (Daniels & Amara 1999, Loder 
& Melikian 2003, Miranda et al 2005, Rao et al 2012). PKC-stimulated DAT endocytosis is 
dependent on the ubiquitination of DAT. PKC activation induces DAT ubiquitination through 
the mediation of an E3 ubiquitin ligase neural precursor cell expressed, developmentally down 
regulated 4-2 (NEDD4-2) (Sorkina et al 2006). A single four-ubiquitin Lys63-linked chain that 
can be conjugated to various N-terminal DAT lysine residues modifies each ubiquitinated DAT 
molecule (Vina-Vilaseca & Sorkin 2010). Ubiquitinated DATs are proposed to be recruited to 
CCPs through ubiquitin adaptor proteins epsin, epidermal growth factor pathway substrate clone 
15 (Eps15), and Eps15-related protein (Eps15R) (Sorkina et al 2006). Ubiquitinated DATs are 
then endocytosed through CME and targeted for degradation through the MVB mechanism 
(Miranda et al 2005). Our laboratory and other research group have not observed PMA-
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stimulated endocytosis in dopaminergic neurons (Eriksen et al 2009, Rao et al 2012). So that it is 
still controversial if it happens in neurons. The model for the mechanism of PKC-stimulated 
DAT endocytosis mediated by ubiquitination is shown in Figure 1.5. 
 
Figure 1.5. Schematic hypothesis of ubiquitination-mediated PKC-stimulated DAT endocytosis, modified from 
(Eriksen et al 2010).  
AMPH treatment (5 min-30 min) triggers DAT endocytosis through the activation of the 
small GTPase RhoA in a dynamin-dependent, clathrin-independent manner (Saunders et al 2000, 
Wheeler et al 2015). AMPH-stimulated DAT endocytosis can be blocked by cocaine, indicating 
that the uptake of AMPH into the cytoplasm by DAT or the DAT conformational change from 
OF to IF state (which can be blocked by cocaine) is required (Johnson et al 2005). AMPH-
stimulated DAT endocytosis is observed in heterologously expressing cells, cultured 
dopaminergic neurons, and midbrain slices (Wheeler et al 2015). Internalized DAT is found 
mostly in EEs and REs under AMPH treatment, in contrast to its efficient targeting to LEs and 
LYSs upon PKC activation (Hong & Amara 2013). It means that during AMPH treatment, 
internalized DAT mostly enter the recycling pathway. The elevated level of cytosol DA that is 
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induced by AMPH treatment may activate RhoA-mediated DAT endocytosis, during which the 
clathrin-light chain does not colocalize with DAT (Wheeler et al 2015). 
In summary, constitutive endocytosed DAT can be sorted to EEs, REs, or LEs in the 
somatodendritic region of dopaminergic neurons, although there are controversies between 
Melikian group and Gether group. The former suggests that internalized DAT recycles back to 
the plasma membrane through the slow-recycling pathway via ERCs (Melikian & Buckley 
1999), while the later suggests that internalized DAT recycles through the fast-recycling pathway 
(Eriksen et al 2010). PKC-stimulated DAT endocytosis in heterologous expression system is 
clathrin-dependent and requires ubiquitination at least in PAE and HeLa cells (Hong & Amara 
2013, Miranda et al 2005), while AMPH-stimulated DAT endocytosis is dynamin-dependent and 
clathrin-independent (Wheeler et al 2015).  
1.4 REGULATION OF DAT FUNCTION BY PROTEIN-PROTEIN INTERACTIONS 
A multitude of proteins that interact with DAT have been found. Protein-protein interactions 
regulate DAT localization, trafficking, activity and degradation. Studies on these interactions 
contribute to revealing mechanisms for the regulation of DAT function.  
The interaction between DAT and scaffolding proteins may regulate DAT localization in 
the presynaptic membrane. DAT binds the PDZ domain-containing protein interacting with C 
kinase 1 (PICK1) through the last three C-terminal residues (LKV) in a heterologous expression 
system (Torres et al 2001). The mutation of LKV to AAA impairs the localization of DAT to the 
presynaptic membrane. However, it is possible that this effect is due to the important role of the 
DAT C-terminus in regulating the trafficking of DAT from the ER to the plasma membrane but 
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not the disruption of the DAT-PICK1 interaction, since the DAT LKV-AAA mutant maintains 
normal expression in the plasma membrane of HEK293 cells (Bjerggaard et al 2004). 
Several DAT interacting proteins are involved in AMPH-stimulated DAT endocytosis 
and conformational changes. CaMKII binds the C-terminus of DAT and phosphorylates the N-
terminus of DAT (Fog et al 2006). DAT interacts with SNARE protein syntaxin1A, which is 
localized to the presynaptic membrane (Lee et al 2004). The interaction between DAT and 
syntaxin1A is dependent on the phosphorylation of the DAT N-terminus by CaMKII, which can 
be activated by AMPH treatment. The overexpression of syntaxin1A in turn facilitates AMPH-
induced DA efflux (Binda et al 2008). However, the mechanisms for this interaction (e.g., the 
binding motifs of DAT) are not known.  
DAT interacts with the β subunit of PKC (PKCβ) (Chen et al 2009). Mice with PKCβ 
knockout exhibit decreased surface DAT levels and DA uptake activity, and reduced AMPH-
induced DAT endocytosis and DA efflux, suggesting that PKCβ maintains normal DAT function 
and plays an important role in AMPH-stimulated DAT endocytosis (Chen et al 2009, Johnson et 
al 2005). However, this is not in agreement with the general observation that PKC is not 
involved in AMPH-stimulated DAT endocytosis. 
Several DAT interacting proteins down regulate the surface level of DAT. The orphan G 
protein-coupled receptor 37 (GPR37) has also been reported to interact with DAT and regulate 
DAT trafficking and endocytosis. Mice with GPR37 knockout exhibit enhanced surface DAT 
levels and elevated DA uptake activity (Marazziti et al 2007). Surface DAT level is also down 
regulated by the interaction between DAT and the focal adhesion protein Hic-5. Overexpression 
of Hic-5 results in the reduction of surface DAT and DA uptake activity (Carneiro et al 2002). 
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DAT also interacts with α-synuclein, although the effect of down-regulation of α-synuclein on 
DAT function remains controversial (Lee et al 2001, Wersinger & Sidhu 2003).   
DAT activity can be regulated by protein-protein interaction directly. The DA uptake 
activity of DAT is increased by its interaction with synaptogyrin-3, a protein that resides in the 
membrane of synaptic vesicles. The effects of synaptogyrin-3 on DAT activity is dependent on 
the vesicular monoamine transporter 2 (VMAT2), suggesting that DAT activity is regulated by 
synaptic vesicles (Egaña et al 2009). It has been shown that D2SR interacts with the N-terminus 
of DAT and stabilizes DAT surface expression and DA uptake activity (Lee et al 2007).  G 
protein βγ subunits interact with DAT and inhibit DA uptake activity or increase DA efflux 
through DAT (Garcia-Olivares et al 2013). 
Several DAT interacting proteins are involved in DAT ubiquitination. DAT is 
constitutively uniquitinated and degraded (Miranda et al 2005). As described in 1.3.4, the 
uniquitination of DAT is enhanced upon PKC activation. DAT ubiquitination is specifically 
regulated by the ubiquitin ligase NEDD4-2, which directly interacts with DAT. Ubiquitinated 
DAT also interacts with ubiquitin adaptor proteins epsin, Eps15, and Eps15R, which are 
important for the recruitment of ubiquitinated proteins to CCPs (Sorkina et al 2006).  
In summary, DAT function is regulated by protein-protein interactions. However, most 
interactions of DAT have been demonstrated in a single study and have not been reproduced 
(Torres 2006). None of the interactions (except through ubiquitin) have shown clear molecular 
mechanisms for the interaction and mapped interacting motifs (Eriksen et al 2010). Most 
interactions have unknown function. Therefore, it is important to perform new screens of DAT-
interacting proteins. 
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1.5 FILOPODIA 
Filopodia are highly dynamic finger-like protrusions of the plasma membrane containing a 
uniform bundle of 15-20 linear actin filaments (Pacheco & Gallo 2016). Filopodia extend from 
the plasma membrane and move rapidly as the cell seeks biological cues. An example of EM 
image of filopodia is shown in Figure 1.6, which is the tomogram of 3D reconstructed of 
filopodia images from cryo-electron tomography. In the filopodia, actin filaments are bundled 
tightly and periodically (left). Cross-section from bottom view shows that actin filaments are 
bundled hexagonally, and the thickness of filopodia is around 200 nm (right). The width of 
mammalian filopodia is about 0.1-0.3 μm (Pertz 2011). 
 
Figure 1.6. The structure of filopodia (Aramaki et al 2014). 
The mechanisms of filopodia formation and maintenance are not fully understood. It is 
suggested that there might be several distinct mechanisms of filopodia formation. One of the 
mechanisms for filopodia formation involving the recruitment of I-BAR (inverse Bin-
Amphiphysin-Rvs) protein IRSp53 to the plasma membrane is the best studied so far (Figure 
1.7). IRSp53 (or other inverse I-BAR domain-containing proteins) facilitate plasma membrane 
protrusion by directly deforming the membrane (from a to b in Figure 1.7). I-BAR domain 
proteins form convex (away from the cytoplasm) dimers and induce the curvature of membrane 
that they bind to (Mattila et al 2007). The activation of active cell division control protein 42 
(Cdc42, a small GTPase of the Rho family) or Rac-related C3 botulinum toxin substrate 1 (Rac1) 
 21 
recruits IRSp53 to the plasma membrane (Scita et al 2008). IRSp53 dimers deform the plasma 
membrane and generate membrane protrusions. The I-BAR domain of IRSp53 also has an actin-
binding site, which may induce the binding of actin filaments. 
 
Figure 1.7. A model for filopodia formation (Mattila & Lappalainen 2008). 
IRSp53 binding partners such as Enabled/vasodilator-stimulated phosphoprotein 
(Ena/VASP) and diaphanous 2 (Dia2) facilitate the barbed end growth of actin filaments by 
protecting them from capping proteins (Scita et al 2008).As the filopodia generate (from b to c in 
Figure 1.7), Dia2 and Ena/VASP are localized to the tip to regulate the elongation of barbed-end 
actin filaments, and the actin crosslinking protein fascin crosslinks actin filaments into semi-
ordered array. However, a number of studies demonstrated that Rho-family GTPases are not 
necessary for filopodia formation. Ena/VASP and Dia2 bind profilin, an actin-binding protein 
enhancing the growth of actin filaments (Romero et al 2004). Therefore, actin filaments are 
recruited to the deformed (bended) membrane and bundle together as they elongate to shape 
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membrane protrusions. A subset of uncapped actin filaments of the actin-related protein-2/3 
(ARP2/3)-nucleated dendritic network is targeted for continued elongation by Dia2 and/or by 
Ena/VASP via preventing the binding of capping proteins.  
Another I-BAR domain protein, missing in metastasis (MIM), which does not bind actin 
filaments, Ena/VASP, or Dia2, is also able to deform the plasma membrane and induce the 
formation of filopodia, suggesting that it may regulate filopodia formation through a different 
mechanism. Several other members of the Rho family small GTPases also regulate filopodia 
formation. For example, Rho in filopodia (Rif) binds Dia2 (Ahmed et al 2010). IRSp53, MIM, 
and profilin bind PIP2, and Ena/VASP binds membrane rafts that are enriched in PIP2, suggesting 
that the protein complex for actin binding may form a staging area with PIP2 during filopodia 
initiation (Lai et al 2008, Mattila et al 2007, Skare & Karlsson 2002).  
A motor protein myosin X (MyoX) also plays an important role in filopodia formation 
(Figure 1.7). MyoX moves up along actin filament barbed ends and then slides down with the 
retrograde actin flow in an ATP-dependent manner. It has been suggested that MyoX carries 
Ena/VASP and a number of focal contact components such as integrins as cargos to the tips of 
filopodia (Heckman & Plummer 2013). It has also been demonstrated that overexpression of 
MyoX induces filopodia formation, as the motor activity of MyoX promotes actin filaments 
convergence (Tokuo et al 2007). MyoX may act downstream of Cdc42, and it can initiate 
filopodia formation without Ena/VASP (Bohil et al 2006) 
Filopodia are involved in many cellular and developmental processes, as reviewed in 
(Mattila & Lappalainen 2008). In particular, in the nervous system, it is thought that filopodia are 
involved in formation of dendritic spines. Filopodia plays an important role in axon 
branching/pathfinding, also called axon guidance, during neuronal growth (Gallo 2011). The 
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function of filopodia as growth cone sensors has been well studied in the dorsal closure in 
embryonic development. When growth cone filopodia of a neuron are contacting the surface of 
another neuron that is destined to interact with it (attractive target), the filopodia will tightly 
attach to the target. When growth cone filopodia of a neuron are contacting the surface of 
another neuron that is not related to it (repulsive target), the filopodia movement in the contact 
place is stopped, while the other filopodia on the growth cone continue to move forward and 
seek other targets (Heckman & Plummer 2013). 
There are no dendritic spines in dopaminergic neurons, and our lab has observed the 
localization of DAT in the filopodia of axons and growth cones of cultured dopaminergic 
neurons (Rao et al 2012). Besides, DAT is accumulated in the membrane protrusions that contain 
filamentous actin and a filopodia actin motor MyoX (Caltagarone et al 2015). DAT has also been 
demonstrated to interact with PIP2 (Hamilton et al 2014), which is essential for the formation of 
filopodia as described above. So far, the role of DAT in filopodia and the mechanism for DAT 
accumulation in filopodia have not been demonstrated. 
1.6 THESIS GOALS AND HYPOTHESES 
The subcellular localization and trafficking of DAT is critical for its proper function. How DAT 
is transported from the soma to the dendrites and axons of dopaminergic neurons is not 
understood. Our laboratory has found that DAT is enriched in filopodia and may induce 
filopodia formation when overexpressed. The capacity of DAT to concentrate in filopodia may 
facilitate synaptogenesis processes during development, or be part of the mechanism by which 
DAT concentrates in striatal axonal processes. In contrast to wild-type DAT, R60A and W63A 
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DAT mutants with disrupted intramolecular interaction and substrate transport function are not 
enriched in filopodia compared to wild-type DAT, suggesting that DAT conformation is 
important for DAT filopodia targeting. Therefore, we hypothesize that filopodia targeting of 
DAT is regulated by DAT conformation.  
On the other hand, our laboratory proposed the existence of plasma membrane retention 
mechanisms that prevent constitutive endocytosis of DAT, maintaining the bulk of the 
transporter at the cell surface. We also found that this retention is mediated by N-terminus. Since 
it has been demonstrated that PIP2 a critical phosphoinositide enriched in the plasma membrane 
and interacts with the N-terminus of DAT (Khelashvili et al 2015), it can be proposed that this is 
the retention mechanism. It has indeed been proposed that the interaction with PIP2 may retain 
DAT in the plasma membrane (Fagan et al 2015). However, PIP2 regulates the function of many 
proteins involved in endocytosis, the actin cytoskeleton and cell adhesion, by recruiting them to 
the plasma membrane. It is also known to bind and modify the function of potassium channels. 
At the same time, PIP2 is involved in clathrin-mediated endocytosis through recruitment of 
various proteins associated with the clathrin-coated pits. Therefore, the role of PIP2 in regulating 
DAT retention in the plasma membrane and its endocytosis is important to elucidate. We 
hypothesize that PIP2 regulates DAT levels at the plasma membrane by preventing constitutive 
endocytosis but also is necessary for endocytosis. It is possible that the retention of DAT in the 
plasma membrane by PIP2 prevents constitutive DAT endocytosis. At the same time, PIP2 is 
necessary for all kinds of endocytosis, because PIP2 is highly associated with cytoskeleton. 
While the role of conformation and lipid binding of PIP2 to DAT are to be tested as 
proposed above, DAT function is likely regulated by protein interactions. As we described 
above, virtually no interactions of DAT with other proteins are understood on the molecular and 
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functional levels. Therefore, it is still important to perform rigorous screening for DAT 
interactors in the brain.  
The overall goal of the dissertation is to study the mechanisms determining subcellular 
localization and trafficking of DAT. We will study the role of DAT conformation and PIP2, in 
DAT targeting to filopodia and subcellular distribution, as well as search for new DAT 
interactors that control DAT localization and function in the cell. 
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2.0  TARGETING OF DAT TO FILOPODIA 
2.1 ABSTRACT 
Dopamine transporter (DAT) has been shown to accumulate in filopodia in neurons and non-
neuronal cells. High levels of DAT expression in non-neuronal cells induce filopodia formation. 
To examine the mechanisms of DAT filopodial targeting, we used quantitative live-cell 
fluorescence microscopy, and compared the effects of the DAT inhibitor cocaine and its 
fluorescent analog JHC1-64 on the plasma membrane distribution of wild-type DAT and two 
non-functional DAT mutants, R60A and W63A, that do not accumulate in filopodia. W63A did 
not bind JHC1-64, whereas R60A did, although less efficiently compared to the wild-type DAT. 
Molecular dynamics simulations predicted that R60A preferentially assumes an outward-facing 
(OF) conformation through compensatory intracellular salt bridge formation, which in turn 
favors binding of cocaine. Imaging analysis showed that JHC1-64-bound R60A mutant 
predominantly localized in filopodia, whereas free R60A molecules were evenly distributed 
within the plasma membrane. Cocaine binding significantly increased the density of R60A, but 
not that of W63A, in filopodia. Further, zinc binding, known to stabilize the OF state, also 
increased R60A concentration in filopodia. Finally, amphetamine, which is thought to disrupt the 
DAT OF conformation, reduced the concentration of wild-type DAT in filopodia. Altogether, 
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these data indicate that the OF conformation is required for the effective targeting of DAT to, 
and accumulation in, filopodia. 
2.2 INTRODUCTION 
DAT conformation dynamically shifts between outward-facing (OF) and inward-facing (IF) 
states during the transport cycle. Maintaining the OF conformation and the OF-IF transition 
leading to the substrate release are critical for the substrate uptake function of DAT. However, 
whether such conformation states (or their transitions) affect subcellular localization of DAT has 
not been elucidated. 
We have previously demonstrated that DAT is accumulated in filopodia-like membrane 
protrusions in dopaminergic neurons and non-neuronal cells (Rao et al 2012, Sorkina et al 2009). 
In our previous studies, we also showed that filopodia tip motor protein myosin X (MyoX) was 
concentrated on the tips of many DAT-labeled membrane protrusions that extended from the cell 
edge, dorsal membrane and large ruffle-like structures (Caltagarone et al 2015). MyoX transports 
cargo proteins towards the tip of filopodia along actin filaments (Sato et al 2017). We proposed 
that the ability to accumulate in the highly curved membranes of filopodia might be enabled by 
the same mechanism that is also responsible for DAT accumulation in dopaminergic axons 
whose dimensions (~200 nm in diameter) and membrane curvature are similar to those of 
filopodia, especially during axonal branching. Based on the observation that DAT mutants with 
disrupted intramolecular interactions and diminished substrate transport activity were not 
enriched in filopodia (Caltagarone et al 2015), we hypothesized that a proper functional 
conformation of the DAT molecule is necessary for its targeting to filopodia, and that DAT can 
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promote filopodia formation when expressed at high levels. Therefore, we directly examine the 
filopodia-promoting ability of DAT and analyze the relationship between DAT filopodia 
targeting and DAT conformational states. We use molecular dynamics (MD) simulations to 
determine the conformational state of two DAT mutants, and define the effects of cocaine and its 
fluorescent analog JHC1-64 on the conformation of these mutants. We then used several 
independent experimental approaches to control the conformational state of DAT and its mutants 
to demonstrate that the OF state of DAT is required for its enrichment in filopodia. 
2.3 MATERIALS AND METHODS 
2.3.1 Reagents 
Cocaine hydrochloride, D-amphetamine hemisulfate salt and ZnCl2 were from Sigma-Aldrich 
(St. Louis, MO). JHC1-64 was synthesized in the Medicinal Chemistry Section, NIDA-IRP as 
described (Cha et al 2005). Restriction enzymes are from New England Biolabs (Ipswich, MA). 
All other chemicals were from Thermo Fisher Scientific (Pittsburgh, PA) or Sigma-Aldrich.  
2.3.2 Plasmids 
Yellow fluorescent protein (YFP)- and hemagglutinin epitope (HA)-tagged human DAT (YFP-
HA-DAT, Addgene plasmid # 90244) and mutant versions of YFP-HA-DAT (R60A and W63A, 
Addgene plasmids # 90245 and #90246, respectively) were described previously (Sorkina et al 
2006, Sorkina et al 2009). RFP-HA-DAT (Addgene plasmid # 90265) was also previously 
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described (Caltagarone et al 2015). To generate the R60A mutation in the template of YFP-DAT 
(no HA tag, Addgene plasmid # 90228) (Sorkina et al 2003), the 1622 bp DAT sequence 
(beginning with bp 242 in DAT cDNA) in YFP-HA-R60A was replaced by the corresponding 
sequence from the YFP-DAT construct using PflMI (5’ end) and SmaI (3’ end) restriction sites. 
The R60A mutation in YFP-DAT (Addgene plasmid # 90247) was confirmed by sequencing. 
Lifeact-RFP was provided by Dr. Lichius (Berepiki et al 2010). 
2.3.3 Cell culture and transfections 
Human HEK293 cells (Invitrogen # R70507) were grown in DMEM with 10% fetal bovine 
serum (FBS, Hyclone, Logan, UT). Porcine aortic endothelial (PAE) cells were originally 
obtained from Dr. B. Westermark (University of Uppsala, Sweden) and used in our previous 
studies (Sorkina et al 2003). PAE cells were grown in F12 medium with 10% FBS. PAE cells 
stably expressing YFP-HA-DAT were described previously (Sorkina et al 2009).  
The cells were transiently transfected with plasmids using Effectene kit (Qiagen, 
Valencia, CA) according to the manufacturer’s protocol. After transfection, HEK293 cells were 
grown on Poly-D-Lysine (Sigma-Aldrich) coated 18 mm glass coverslips and PAE cells were 
grown on coverslips without coating. Cells were used for imaging 2 days after transfection. 
2.3.4 Fluorescence microscopy 
Cells grown on glass coverslips were placed onto the stage of a spinning disk confocal imaging 
system equipped with an EM-CCD camera and an environmental chamber controlled by 
SlideBook software (Intelligent Imaging Innovation, Denver, CO). A 63x oil immersion lens was 
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used (207 nm/pixel). For JHC1-64, cocaine and zinc binding experiments, cells were imaged in 
Dulbecco’s Phosphate Buffered Saline (DPBS) (plus 1 mM CaCl2, 0.5 mM MgCl2 and 5 mM D-
glucose) at room temperature (RT). For AMPH treatment experiment, cells were imaged in 
Krebs Ringer HEPES solution (KRH, with 140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM 
MgCl2, 5.5 mM HEPES and 1 mM D-glucose, pH 7.4), at 37 °C and 5% CO2. A z-stack of 15-20 
confocal images at 400 nm z-steps was acquired through 515 nm (YFP) or 561 nm (RFP and 
JHC1-64) laser channels using a single dichroic. All images were captured using the same 
exposure time (100 ms) and all other image acquisition parameters were also kept the same. 
Gamma was set on “1” in all images if not specified. 
2.3.5 Image analysis 
Images were analyzed using SlideBook software. The use of an EM-CCD camera allows high 
linearity of fluorescence detection within the full intensity range. Background was subtracted in 
each image. To count filopodia, a maximum projection image was generated from a 3D image, 
and a mask was generated to manually select the entire cell. The lengths of filopodia were 
measured using the line tool in SlideBook software. Filopodia longer than 2 μm were counted in 
a blind fashion. The cell body was selected manually using the SlideBook mask pencil tool, and 
the perimeter of the cell was calculated using the statistics module of SlideBook software. The 
filopodia density was expressed as the number of filopodia per 100 μm of cell perimeter. 
To facilitate quantitation of JHC1-64 binding, a segmental mask was generated to select 
YFP-containing voxels in each individual cell. The mean fluorescence intensities (in arbitrary 
linear units of fluorescence intensity) of JHC1-64 and YFP were calculated in the mask, and the 
ratio of JHC1-64 and YFP fluorescence, designated as JHC/YFP, was used to estimate the 
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apparent density of the JHC1-64:YFP-HA-DAT complexes. YFP intensities were corrected for 
photobleaching whereas no significant photobleaching of JHC1-64 fluorescence was observed 
during time-course imaging.  
To quantitate the ratio of JHC1-64 to YFP-HA-DAT fluorescence intensities in filopodia 
versus non-filopodial regions of the plasma membrane (FM, flat membrane), 5 xy-confocal 
planes from the z-stack that encompasses most of the peripheral filopodia and cell-bottom 
plasma membrane were used for quantification. Peripheral filopodia were selected manually 
using the SlideBook mask pencil tool in each z-plane (Mask 1). A mask containing all YFP-
containing voxels in the cell was also generated using automated segmentation (Mask 2). The 
overlapping voxels of Masks 1 and 2 were then selected to generate Mask 3 (filopodia) to 
minimize the error of the manual selection of YFP-positive voxels. Ten or more representative 
small regions of FM in the periphery of the cells were manually selected to generate FM Mask 4. 
This mask typically included fluorescence of both bottom and top cell surface due to a limited z-
axis resolution. Mean fluorescence intensities (in arbitrary linear units of fluorescence intensity) 
of JHC1-64 and YFP in Mask 3 and Mask 4 were then calculated in each cell, and the JHC/YFP 
ratio was used to estimate the relative density of JHC1-64:YFP-HA-DAT complexes in filopodia 
(Mask3) and non-filopodial plasma membrane (Mask4). 
To quantitate the relative density of YFP-HA-DAT fluorescence in filopodia and non-
filopodial regions of the plasma membrane (FM), filopodia (Mask 3) and FM (Mask 4) masks 
were generated from 5 xy-confocal planes from full z-stack of images as described above for 
experiments with JHC1-64. The mean YFP fluorescence intensities of filopodia Mask 3 and FM 
Mask 4, and their ratio (Filopodia/FM) were calculated in individual cells.  
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In cells co-expressing YFP- and RFP-tagged DATs, filopodia (Mask 3) and FM (Mask 4) 
masks were generated as described above, and the ratio of mean YFP and RFP fluorescence 
intensities in Mask 3 to Mask 4 were calculated for each individual cell to obtain filopodia/FM 
ratio values for YFP-HA-DATs and RFP-HA-DAT, respectively. Furthermore, the values of 
YFP filopodia/FM ratio were divided by values of the RFP filopodia/FM ratio in each individual 
cell to obtain a YFP/RFP value that corresponds to the relative fluorescence of YFP-HA-DAT 
versus RFP-HA-DAT in filopodia. 
2.3.6 Statistical analysis 
All data were analyzed using GraphPad Prism 6.0. Data normality of all data sets was 
confirmed using the D’Agostino-Pearson test. Student t-test was used to compare the statistical 
differences. For the comparison of the ratios of the same cells before and after JHC1-
64/cocaine/zinc binding or AMPH treatment, paired student t-test was used. In other cases, we 
used unpaired student t-test. In all the figures, bar graphs show the mean value of quantified 
results, and error bars represent the S.E.M. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
2.4 RESULTS 
2.4.1 Expression of DAT induces filopodia formation 
To better characterize DAT-containing filopodia, we performed time-lapse 3D imaging of live 
PAE cells stably expressing YFP-HA-DAT at 37 °C. Maximal intensity projection images of the 
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z-stack are presented in Figure 2.1. Same cells in different time frames (times are in seconds) are 
shown in the figure. The arrows point to protruding and retracting movements of membrane 
extensions. The scale bar is 10 μm. Peripheral and dorsal filopodia were highly mobile with rapid 
lateral, protruding and retracting motions at 37 °C, which distinguishes them from retraction 
fibers (Figure 2.1). Similar though less dramatic dynamics was detected at room temperature 
(data not shown). 
 
Figure 2.1. DAT-containing filopodia are highly mobile. 
From our visual inspection of the images, cells with high expression level of DAT tended 
to have more DAT-containing filopodia. Therefore, we tested whether wild-type DAT can 
promote filopodia formation. PAE cells were transfected with Lifeact-RFP to label F-actin, and 
with YFP-HA-DAT or YFP. Z-stacks of 10 confocal images (400 nm stepsize) of living cells 
was acquired through 515 (YFP) and 561 (RFP) channels at 37°C. One group of the images is 
shown in Figure 2.2A. The RFP image is presented with the gamma for the 561 channel set to 
0.5 to allow for better visualization of the low Lifeact-RFP signals in filopodia without 
interference from the bright signal of the cell cortex. The insets show high magnification of the 
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region marked by the white rectangle to demonstrate enrichment of YFP-HA-DAT in distal 
filopodia regions compared to Lifeact-RFP. Live-cell 3D imaging of Lifeact-RFP revealed large 
stress fibers in the cell body and smaller filaments that were detected in filopodia containing 
YFP-HA-DAT, although Lifeact-RFP did not penetrate into distal parts of these filopodia 
(Figure 2.2A). Figure 2.2B shows an example of the selection mask used for counting peripheral 
filopodia. The mask was manually generated by encircling the perimeter of the cell Lifeact-RFP 
fluorescence. Filopodia extending for more than 2 μm outside of the mask were marked. The 
perimeter of the cell body was calculated and the number of filopodia was counted using the 
SlideBook statistics module. In the example presented in Figure 2.2 B, there are 11.6 filopodia 
per 100 μm of cell perimeter. Figure 2.2C shows an example of PAE cells with transiently 
expressed YFP and Lifeact-RFP, and the mask selection for counting peripheral filopodia. There 
are 4.5 filopodia per 100 μm of cell perimeter in this image. Figure 2.2D shows the 
quantifications of the filopodia density (number per 100 μm of cell perimeter). The statistical 
difference between cells expressing YFP-HA-DAT and YFP was analyzed using unpaired 
student t-test. Graph bars represent mean values of filopodia number per cell perimeter from 30 
to 40 cells in each experimental variant. The scale bars are 10 μm. Analysis of Lifeact-RFP 
images revealed a statistically significant increase in the peripheral filopodia membrane density 
in cells expressing YFP-HA-DAT over control cells (expressing YFP and Lifeact-RFP) as 
measured by the number of filopodia per unit of the cell perimeter (Figure 2.2D). 
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Figure 2.2. DAT induces filopodia formation. 
PAE cells expressing YFP-HA-DAT or YFP were fixed and stained with MyoX. 
Numbers of MyoX positive filopodia tips were counted. The analysis also demonstrated a high 
number of filopodia in cells expressing YFP-HA-DAT (Figure 2.2D). Finally, PAE cells were 
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co-transfected with EGFR-ΔC ΔC (model transmembrane homogeneously distributed in the 
plasma membrane) and YFP-HA-DAT or YFP. In these experiments, an increased density of 
EGFR-ΔC labeled filopodia was observed in YFP-HA-DAT expressing cells as compared to 
control (YFP) cells (Figure 2.2D). 
In all three approaches, the number of peripheral filopodia per length of the perimeter of 
the cell was calculated. Dorsal filopodia were difficult to count, especially in fixed cells, because 
of their overlap with the strong fluorescence of actin, MyoX and EGFR-ΔC staining throughout 
the perinuclear area of the cell. However, it is likely that the numbers of DAT-enriched filopodia 
were underestimated because Lifeact-RFP and EGFR-ΔC did not penetrate to the entire length of 
DAT-enriched filopodia, and may therefore, be undetectable in short filopodia. Nevertheless, all 
three approaches to detect and count filopodia indicated that DAT can induce and/or maintain 
filopodia in both transiently and stably DAT-expressing cells.  
2.4.2 DAT mutants W63A and R60A do not concentrate in filopodia 
Demonstration of DAT accumulation in filopodia prompted the investigation of the mechanism 
of DAT filopodia targeting. We have previously observed that DAT mutants with disrupted 
substrate uptake activity appear not to concentrate in membrane protrusions (Sorkina et al 2009). 
To directly compare the localization of wild-type and mutant DATs, RFP-HA-DAT was 
transiently co-expressed with W63A or R60A mutants of YFP-HA-DAT in PAE cells. Cells 
were imaged through 561 (RFP) and 515 (YFP) filter channels. Maximal projection images of 
3D images are presented in Figure 2.3A and C. The insets show high magnification of the region 
marked by the white rectangle to demonstrate the enrichment of RFP-HA-DAT in distal 
 37 
filopodia regions as compared to DAT mutants. The scale bars are 10 μm. Both DATs were 
highly co-localized in all areas of the cell including in filopodia (Figure 2.3A, C).  
In each image, the RFP/YFP fluorescence ratio in filopodia and planner flat membrane 
(flat membrane, FM, where we observed a diffuse distribution of DAT) was quantified. The 
statistical difference between the ratios of filopodia and FM was analyzed using paired student t-
test. The quantification of RFP/YFP ratios from 30 to 35 cells are shown in Figure2.3B and D. 
Interestingly, the ratio of RFP to YFP fluorescence intensities (RFP/YFP) in filopodia was 
substantially higher than in other regions of the cell (Figure 2.3B, D). The difference in scale 
between Figure 2.3B and Figure 2.3D is big, this is probably because the instability of transient 
expression of RFP-HA-DAT and the mutants. In fact, distal parts of many RFP-HA-DAT 
containing filopodia did not contain detectable amounts of W63A or R60A mutants regardless of 
the expression levels of wild-type and mutant DATs. The extent of the differential distribution of 
wild-type versus mutant DAT observed in co-expression experiments was probably 
underestimated because of wild-type/mutant DAT hetero-oligomerization (Sorkina et al 2003, 
Torres et al 2003). These two non-filopodial targeting mutants R60A and W63A were highly 
useful for further studying the mechanisms of DAT filopodia targeting. 
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Figure 2.3. DAT mutants are not enriched in filopodia. 
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2.4.3 Fluorescent cocaine analog JHC1-64 preferentially binds to filopodia-located DAT 
and its R60A mutant 
To quantitatively compare the distribution of the wild-type (wt) DAT and the mutants in the 
plasma membrane, we used JHC1-64 (the chemical structure is shown in Figure 2.4A), a 
membrane-impermeable fluorescent cocaine analog, to detect surface YFP-HA-DAT (Cha et al 
2005). It was previously shown that JHC1-64 does not alter the membrane mobility and 
trafficking properties of DAT (Eriksen et al 2009). Transient expression of wt YFP-HA-DAT 
and its mutants was used to avoid clonal variations of stably expressing cells, and differences in 
expression levels of wt and mutant DATs in these clones.  
HEK293 cells transiently expressing wt YFP-HA-DAT, or its mutants (R60A or W63A) 
were incubated with 100 nM JHC1-64 for 30 min at room temperature (RT). Live-cell imaging 
was performed at RT to minimize the motility of highly dynamic filopodia during 3D image 
acquisition. Images were acquired through 515 nm (YFP, green) and 561 nm (JHC1-64, red) 
filter channels. Maximal projections of 5 z-planes are shown in Figure 2.4B. The arrows point to 
examples of peripheral filopodia. The scale bars are 10 μm. JHC1-64 bound to the R60A mutant, 
albeit to a lesser extent than to wt YFP-HA-DAT. By contrast, no detectable binding of JHC1-64 
to the W63A mutant was observed (Figure 2.4B). YFP-HA-DAT wt and the R60A mutant were 
treated with 10-200 nM JHC1-64 for 30 min at RT. The ratio of JHC1-64 and YFP fluorescence 
intensities (designated JHC/YFP) was quantitated for whole cells as described in section 2.3.5. 
The statistical difference between the ratios of wt YFP-HA-DAT and the R60A mutant in each 
dose of JHC1-64 was analyzed using unpaired student t-test (n=3) (Figure 2.4C). A JHC1-64 
concentration of 100 nM was found to yield the best signal-to-noise fluorescence ratio in cells 
expressing wt YFP-HA-DAT or the R60A mutant. 
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Figure: 2.4. Preferential binding of JHC1-64 to wt DAT and its R60A mutant in filopodia and cell edges of 
HEK293 cells. 
HEK293 cells with transiently expressed YFP-HA-DAT or YPP-HA-R60A were treated 
with 100 nM JHC1-64, and the time dependence of the JHC/YFP ratio was determined by time-
lapse imaging of YFP and JHC1-64 at RT. The statistical difference between the ratios of wt 
YFP-HA-DAT and the R60A mutant in each time point was analyzed using unpaired student t-
test (n=10). As shown in Figure 2.4D, quantification of the JHC1-64/YFP ratio during the time-
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course of JHC1-64 (100 nM) binding to wt YFP-HA-DAT and the R60A mutant using single-
cell imaging showed that binding to either DAT approached a maximum after 20-30 min at RT, 
and that binding to the R60A mutant was 2-times less efficient than that to wt YFP-HA-DAT. 
Binding of JHC1-64 at 37 °C was much faster compared to that at RT (maximum binding to wt 
YFP-HA-DAT was reached at 1 min), while the pattern of JHC1-64 localization was identical to 
that observed at RT. No significant dissociation of JHC1-64 was observed after washing out 
JHC1-64 for at least 1 hour at 37 °C, suggesting that the JHC1-64 dissociation rate constant is 
low (data not shown).   
Visual inspection of JHC1-64 localization revealed a striking preference of JHC1-64 to 
decorate filopodia and cell edges, areas of increased membrane curvature (Figure 2.4B).  
Accumulation of both JHC1-64 and YFP-HA-DAT (indicative of the formation of JHC1-
64:YFP-HA-DAT complexes) was most pronounced in filopodia emanating near cell-cell 
contacts. The ratio of the fluorescence intensities of JHC1-64 and YFP-HA-DAT, designated as 
JHC/YFP, was adopted as a measure of the JHC1-64 binding fraction (see section 2.3.5). To 
compare the JHC/YFP ratio in the filopodia to that in regions of the planar plasma membrane 
(FM, flat membrane), peripheral filopodia and FM masks were generated in each cell. Figure 
2.4E shows an examples of the segmentation masks for quantification of the mean fluorescence 
intensities of peripheral filopodia (left) and non-filopodial membrane (FM; right) regions from 
YFP images obtained in the experiments represented in Figure 2.4B. JHC/YFP ratio values were 
quantified in the peripheral filopodia because DAT density in dorsal filopodia is technically 
difficult to measure due to limited z-axis resolution. 
To quantitatively analyze whether there is more JHC1-64 binding in filopodia than FM, 
HEK293 cells expressing YFP-HA-DAT wt or R60A were imaged after incubation with 100 nM 
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JHC1-64 for 30 min at RT. The JHC/YFP ratio in filopodia and FM masks was quantitated in 
individual cells. Each ratio of cell expressing wt YFP-HA-DAT or the R60A mutant was divided 
by the mean value of the ratios in the FM mask of wt YFP-HA-DAT or the R60A mutant, 
respectively. The statistical difference between the ratios of filopodia and FM masks was 
analyzed using unpaired student t-test (n=10). The quantification results are shown in Figure 
2.4F. This analysis revealed that the JHC1-64 binding fraction was at least 2-fold higher in 
filopodia than in flat membrane regions. The same behavior was observed in cells expressing the 
R60A mutant. These data suggest that both wt YFP-HA-DAT and its R60A mutant either bind 
JHC-64 more efficiently in filopodia or move to filopodia after JHC1-64 binding 
2.4.4 JHC1-64 and cocaine increase R60A concentration in filopodia 
The observation of a high concentration of the JHC1-64-bound R60A mutant in filopodia 
prompted us to test whether JHC1-64 binding promotes targeting of this mutant to filopodia or 
whether those mutant transporters already located in the filopodia exhibit a higher propensity to 
bind JHC1-64.  
To this end, HEK293 cells transiently expressing YFP-HA-DAT wt or R60A were 
incubated with 100 nM JHC1-64 for 30 min at RT. Live-cell imaging was performed through 
515 nm (YFP, green) and 561 nm (JHC1-64, red) filter channels. Maximal z-projections of 5 
consecutive x-y confocal planes are shown in Figure 2.5A. The scale bars are 10 μm. The insets 
representing high magnification images of the regions marked by the white rectangle in Figure 
2.5A are shown in Figure 2.5B. The arrows point to representative filopodia. The Filopodia/FM 
ratios of mean intensities of the YFP fluorescence were calculated as described in section 2.3.5. 
The statistical difference between the ratios of individual cells before and after JHC1-64 binding 
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is analyzed using paired student t-test (n=10) and is shown in Figure 2.5C. These experiments 
demonstrated that binding of JHC1-64 increased the filopodia/FM ratio of the YFP fluorescence 
intensity in cells expressing the R60A mutant by 50%, suggesting an elevated targeting of R60A 
mutant to filopodia in the presence of JHC1-64 (Figure 2.5). The distribution of wt YFP-HA-
DAT in filopodia was not significantly affected by JHC1-64 (Figure 2.5). Similar filopodia 
targeting effect of JHC1-64 on R60A (increase in the filopodia/FM ratio by ~30%) was observed 
in PAE cells (data not shown). 
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Figure 2.5. Binding of JHC1-64 increases the concentration of R60A in filopodia of HEK293 cells. 
We further tested whether unlabeled cocaine, that has slightly lower binding affinity than 
JHC1-64 for DAT but is available for use in high concentrations allowing a maximum 
occupancy of surface DATs, would also cause the re-distribution of the R60A mutant toward 
filopodia. Cells transiently expressing wt YFP-HA-DAT, or its R60A and W63A mutants were 
incubated with 10 μM cocaine for 30 min at RT. Live-cell imaging was performed through the 
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515 nm (YFP, green) filter channel. Maximal z-projections of 5 consecutive x-y confocal planes 
are shown in Figure 2.6A. Figure 2.6B show the insets representing high magnification images 
of the regions marked by the white rectangle in Figure 2.6A. And the arrows point to 
representative filopodia. Consistent with the effects of JHC1-64 (Figure 2.5C), the filopodia/FM 
ratio in HEK293 cells expressing the R60A mutant increased by 60 % after cell incubation with 
cocaine, whereas the subcellular distribution of wt YFP-HA-DAT did not change (n=10) (Figure 
2.6C). Similar results were observed in PAE cells where the filopodia/FM ratio of the R60A 
mutant increased by 70% after cocaine treatment (data not shown). Cocaine treatment did not 
result in increased targeting to filopodia of the W63A mutant that does not bind JHC1-64, 
confirming that elevated filopodial targeting of R60A was mediated by cocaine through its 
binding to this mutant transporter (Figure 2.6C).  
 
Figure 2.6. Binding of cocaine increases the concentration of R60A (but not W63A) in the filopodia of HEK293 
cells. 
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We further examined the effect of cocaine on the filopodia targeting of DAT mutants 
using an independent quantitative imaging approach: YFP-HA-DAT or its mutants were co-
expressed with wt RFP-HA-DAT in HEK293 cells, and the cells were imaged through 515 nm 
(YFP, green) and 561 nm (RFP, red) filter channels before and after cocaine treatment. This 
approach enabled direct comparison of the local densities and localization of wt (referred to 
YFP-HA-DAT and RFP-HA-DAT) and mutant DATs (YFP-HA-R60A and YFP-HA-W63A) in 
filopodia and FM regions in single cells imaged before and after cocaine incubation.  
HEK293 cells co-expressing RFP-HA-DAT with YFP-HA-DAT, YFP-HA-R60A or 
YFP-HA-W63A were imaged before and after cocaine treatment (30 min at RT). Maximal z-
projections of 5 consecutive x-y confocal planes are shown in Figure 2.7A. Insets representing 
high magnification images of the regions marked by the white rectangles in Figure 2.7A are 
shown in Figure 2.7B. Overall, YFP-tagged DATs were co-localized with RFP-HA-DAT in the 
images. 
The filopodia/FM ratios of YFP and RFP fluorescence intensities in cells co-expressing 
RFP-HA-DAT with YFP-HA-R60A (Figure 2.7C), YFP-HA-W63A (Figure 2.7D) or wt YFP-
HA-DAT (Figure 2.7E) were calculated as described in section 2.3.5. The statistical difference 
between the ratios of individual cells before and after cocaine binding was analyzed using paired 
student t-test (n=10). The filopodia/FM ratio of the R60A mutant was increased upon binding of 
cocaine by ~2-fold (Figure 2.7C), whereas the filopodia/FM ratios of wt YFP-HA-DAT and the 
W63A mutant were not significantly changed (Figure 2.7D, E). The YFP/RFP ratio in filopodia 
was calculated and the statistical difference between the ratios of individual cells before and after 
cocaine binding was analyzed using paired student t-test (n=10). The results suggested that 
cocaine caused a relatively stronger enrichment of the R60A mutant than wt RFP-HA-DAT in 
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filopodia, whereas the YFP/RFP ratio in cells expressing YFP-HA-W63A and RFP-HA-DAT 
was not increased by cocaine (Figure 2.7F), consistent with the inability of W63A mutant to bind 
cocaine. The data in Figure 2.7 are in agreement with the results presented in Figure 2.5 and 
Figure 2.6, and altogether these measurements demonstrate that binding of either cocaine or its 
analog JHC1-64 favors localization of the R60A mutant to filopodia. 
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Figure 2.7. Binding of cocaine results in the enrichment of the R60A mutant in the filopodia of HEK293 cells 
relative to co-expressed wt DAT. 
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2.4.5 Modeling of the binding of cocaine and JHC1-64 to wt and mutant DAT (performed 
by Mary Cheng and Ivet Bahar) 
To gain a mechanistic understanding of the effect of cocaine or JHC1-64 on the distribution of 
wt and mutant DATs on the plasma membrane (as demonstrated in Figures 2.4-2.7), a series of 
MD and docking simulations were performed by Mary Cheng and Ivet Bahar. MD simulations 
showed that the W63A mutant is stable in the IF state due to weakened interactions between the 
TM1a, TM5 and TM6b segments, while the weakening of the IC interactions in the R60A 
mutant was compensated via re-distribution of salt bridges. It suggests that wt DAT and the R60 
mutant maintain their access to the OF state, while W63A does not (Figure 2.8A). In wt DAT, 
the salt-bridge R60-D436 and close interactions between W63 and F332 and Y335 stabilize the 
substrate/sodium-binding site in the OF state. In the mutant W63A, substitution of W63 by 
alanine breaks the stabilizing network of molecular interactions, leading to the opening of the IC 
vestibule. Substitution of R60 by alanine breaks the salt-bridge R60-D436. Yet, alternative IC 
salt bridges such as R260-E61 maintain the closed state of the IC vestibule. Docking simulations 
demonstrated that cocaine binds near the S1 site of R60A and the S1 and S2 sites of wt DAT 
(Figure 2.8B), whereas there is no cocaine binding inside the EC vestibule of W63A (data not 
shown), suggesting that binding of cocaine can stabilize the R60A mutant (but not the W63A 
mutant) in the OF state, similar to its action on the wt DAT (Chen et al 2000, Dehnes et al 2014). 
The predicted binding poses of JHC1-64 to DAT (Figure 2.8C) were comparable to those of 
cocaine in the OF state of DAT. Notably, JHC1-64 bound to both sites S1 (interacting with D79 
at the lower portion of the EC vestibule) and S2 (at the upper portion of the EC vestibule). Like 
cocaine, JHC1-64 did not show any docking occupancy inside the EC vestibule of W63A (data 
not shown). On the other hand, JHC1-64 was able to bind deep inside the EC vestibule of the 
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R60A mutant (Figure 2.8C). These results were consistent with observations made in live-cell 
imaging experiments (Figure 2.4). Overall, the MD simulations and docking analysis predict that 
binding of cocaine or JHC1-64 stabilizes the OF conformation of both wt DAT and the R60A 
mutant. 
 
Figure 2.8. Cocaine and its analog bind to and stabilize the outward-facing (OF) state of the wt DAT and the R60A 
mutant (Mary Cheng, Bahar lab). 
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2.4.6 Zinc increases the concentration of R60A in filopodia 
To test whether the stabilization of the OF state by means other than cocaine binding 
would drive R60A mutant DAT to filopodia, the effect of zinc on DAT localization was tested. 
Zinc binding to the EC residues in DAT (e.g. H193, D206, H375 and E396 in the EL2 and EL4 
loops) has been reported to shift its conformational equilibrium towards the OF state (Loland et 
al 2002, Stockner et al 2013). Binding of zinc was shown to partially rescue the uptake activity 
of the R60A mutant, presumably, by stabilizing the OF conformation of this mutant (Kniazeff et 
al 2008). Therefore, we examined if zinc increased the concentration of the R60A mutant in 
filopodia. Because H193 was mutated to tyrosine in YFP-HA-DAT to incorporate the HA tag, 
these experiments were performed in wt and mutant YFP-DAT lacking the HA tag. HEK293 
cells transiently expressing wt YFP-DAT or the YFP-DAT R60A mutant were imaged before 
and after incubation with 10 μM zinc chloride for 30 min at RT. Images were acquired through 
the 515 nm (YFP, green) filter channel. Maximal z-projections of 5 consecutive x-y confocal 
planes are shown in Figure 2.9A. The scale bars are 10 μm. Figure 2.9B show the insets 
represent high magnification images of the regions marked by the white rectangle in Figure 
2.9A. The arrows point to examples of peripheral filopodia. The filopodia/FM ratios of YFP 
fluorescence intensities were quantified, and the statistical difference between the ratios of 
individual cells before and after zinc binding was analyzed using paired student t-test (n=10) 
(Figure 2.9C). The filopodia/FM ratio of YFP-R60A fluorescence increased by ~40% after zinc 
treatment, whereas this ratio did not change for wt YFP-DAT (Figure 2.9). These results 
provided cocaine-independent evidence that shifting an equilibrium of DAT conformational state 
towards the OF conformer increases the concentration of R60A in filopodia. 
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Figure 2.9. Binding of zinc increases the concentration of R60A in filopodia of HEK293 cells. 
2.4.7 AMPH reduces DAT density in filopodia 
In Figures 2.4-2.7 and 2.10, we demonstrated that stabilizing an OF state of the R60A 
mutant drives the enrichment of the mutant in the filopodia. To test whether the reverse change, 
i.e. an alteration in the conformation of wt DAT favoring an IF state, affects transporter 
redistribution in the plasma membrane in the opposite direction, HEK293 cells expressing YFP-
HA-DAT were treated with AMPH. AMPH is transported by DAT into the cell where it activates 
signaling pathways leading to phosphorylation of the N-terminus of DAT, which in turn results 
in the reverse substrate transport activity of DAT (efflux) that has been attributed to a shift in the 
equilibrium distribution of DAT conformation towards its IF state (Cheng et al 2015, Fog et al 
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2006, Guptaroy et al 2011). To test the binding efficiency of JHC1-64 to DAT after AMPH 
treatment, HEK293 cells transiently expressing YFP-HA-DAT were treated with AMPH or 
vehicle (control) at 37 °C for 1 hr, followed by 10 min incubation of 100 nM JHC1-64 at RT. 
Images were acquired through 515 nm (YFP, green) and 561 nm (JHC1-64, red) filter channels. 
The ratio of JHC1-64 and YFP fluorescence intensities (JHC/YFP) was calculated for individual 
cells. The statistical difference between the ratios of cells with AMPH and vehicle treatment was 
analyzed using unpaired student t-test (n=5). The results showed that cells expressing YFP-HA-
DAT that were treated with AMPH for 1 hour at 37 °C did not efficiently bind JHC1-64 as 
compared with the vehicle-treated cells (Figure 2.10A), indicating that the OF conformation of 
DAT was indeed disrupted after AMPH treatment.  
To test whether AMPH treatment affects the distribution of DAT in filopodia, HEK293 
cells transiently expressing YFP-HA-DAT were incubated with 10 μM AMPH or vehicle in 
KRH at 37°C for 30 min, and live-cell imaging was performed through 515 nm (YFP, green) 
filter channel. Maximal z-projections of 5 consecutive x-y confocal planes are shown in Figure 
2.10B. The insets representing high magnification images of the regions marked by the white 
rectangle in Figure 2.10B are shown in Figure 2.10C. The arrows point to examples of peripheral 
filopodia. The statistical difference between the filopodia/FM fluorescence intensity ratios of 
individual cells before and after treatment was analyzed using paired student t-test (n=10) 
(Figure 2.10D). The fluorescence of YFP-HA-DAT in filopodia was decreased by the 30-min 
AMPH treatment at 37 °C (Figure 2.10B-D). These results further supported the close 
relationship between the stabilization of the OF state of DAT and its propensity to target DAT to 
filopodia. 
 54 
 
Figure 2.10. AMPH treatment reduces the concentration of wt DAT in the filopodia of HEK293 cells. 
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2.5 DISCUSSION 
To study the mechanism for DAT targeting to filopodia, we utilized several approaches to 
control the conformational state of DAT molecules and performed quantitative live-cell imaging. 
We have demonstrated that 1) the OF state of DAT promotes its targeting to filopodia, and 2) 
heterologously overexpressed DAT may induce filopodia formation.  
To study the mechanism of DAT accumulation in filopodia, we used the R60A mutant of 
DAT as the main experimental model. R60A does not transport substrate and is not concentrated 
in filopodia (Kniazeff et al 2008, Sorkina et al 2009), but unlike another non-functional DAT 
mutant, W63A, is capable of binding cocaine and its analogs. The ability of R60A to bind 
cocaine and its analogs was demonstrated using a fluorescent cocaine analog JHC1-64 (Figure 
2.4) and by MD and docking simulations (Figures 2.8). Docking simulations also suggested that 
cocaine and JHC1-64 binding tends to stabilize the OF state of wt DAT or R60A, but not W63A 
(Figure 2.8). Importantly, binding of cocaine or its analog to R60A drives this mutant to 
filopodia, while the same compounds do not affect localization of the W63A mutant (Figures 
2.5-2.7). Because there is no evidence that R60A and W63A mutations affect the interaction of 
DAT with other proteins, we assumed that the effects of these two mutations on substrate 
binding and filopodia localization are due to destabilized DAT molecule conformation, which is 
in agreement with previous reports (Chen et al 2001, Kniazeff et al 2008). However, mass-
spectrometry studies should be performed to formally eliminate the possibility of altered 
interactions of R60A and W63A mutants as compared to wt DAT. 
The prediction of the role of the OF DAT conformation in filopodia targeting was further 
supported by the observation of the increased targeting of R60A to filopodia by stabilizing the 
OF state of R60A by zinc binding (Figure 2.9). The molecular mechanisms of the zinc effect on 
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DAT conformation are not fully understood, although the hypothesis of “correcting” DAT 
conformation by zinc is supported by the rescue of the substrate uptake activity of the R60A 
mutant by zinc (Kniazeff et al 2008).  
Interestingly, binding of cocaine or JHC1-64 did not change the distribution of wt DAT 
between non-filopodial and filopodia domains of the plasma membrane in our experiments 
(Figures 2.4-2.7). This result is consistent with the original studies where JHC1-64 did not 
change the surface expression and endocytosis of DAT (Eriksen et al 2009). It is possible that the 
bulk of the transporter is present in the OF state in the absence of substrates, and therefore, 
stabilizing the OF state by cocaine or JHC1-64 does not significantly increase the pool of the wt 
DAT OF conformer. Indeed, wt DAT is significantly enriched in filopodia, cell edges, and 
nanotubes at steady-state (Caltagarone et al 2015), and the data in Figure 2.4 show that JHC1-64-
occupied wt DAT (OF state) is accumulated in these regions of the membrane with high 
curvature. On the other hand, it has been shown using cell surface biotinylation that cocaine 
increased the plasma membrane concentration of wt DAT (Kahlig & Galli 2003). Such up-
regulation of surface DAT at the cell surface could be due to accumulation of cocaine-occupied 
DAT in filopodia, which serves in part to protect DAT from endocytosis (Sorkina et al 2009). It 
is possible that the magnitude of the effects of cocaine on the subcellular distribution of DAT is 
dependent on total cellular levels of DAT, and that uncovering such effects requires a highly 
sensitive DAT localization detection assay. 
One can predict that cocaine may stabilize DAT at the surface of dopaminergic neurons, 
and possibly in juxtasynaptic membrane, leading to increased density of synapses in the striatum. 
However, long-term cocaine administration was shown to reduce the density of DA terminals in 
the striatum (Lee et al 2011). Such an effect is likely due to the oxidative stress caused by 
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increased extracellular DA in the presence of cocaine, or a homeostatic mechanism to maintain 
normal DA level.  
Additional evidence in support of the hypothesis of the filopodial localization of the OF 
conformation of DAT was obtained using cell treatment with AMPH that decreased the density 
of wt DAT in filopodia (Figure 2.10). The molecular details of the AMPH effect on the DAT 
conformational state are not fully defined, although AMPH, like DA, is predicted to drive a 
structural transition toward the IF state of DAT (Cheng & Bahar 2015, Cheng et al 2015, 
Khelashvili et al 2015, Shan et al 2011). AMPH activates CaMKII, leading to phosphorylation of 
the N-terminus of DAT, which is proposed to alter DAT conformation in favor of substrate 
binding to the IC site and its reverse transport (efflux) (Fog et al 2006). Re-distribution of a pool 
of DAT from filopodia to the non-filopodial membrane by AMPH detected by quantitative 
image analysis is consistent with the observation of AMPH-induced DAT endocytosis (Saunders 
et al 2000, Wheeler et al 2015), given the surface-retention function of the filopodia localization 
of DAT (Sorkina et al 2009). Long-term AMPH administration also reduces DA terminal 
density, although it is likely due to the dopaminergic degeneration induced by increased 
extracellular DA levels (Cadet et al 2007).   
Based on our previous observations and the findings in the present study, we propose a 
hypothetical model describing the regulation of DAT localization in the membrane by its 
molecular conformational state (Figure 2.11A). An atomic structure of DAT in the OF state 
shows that the TM core of the molecule has a concave shape with the diameter of the 
cytoplasmic interface of the core smaller than that of the EC interface (Penmatsa et al 2013). 
Therefore, the OF state of wt DAT and cocaine-bound R60A mutant are stabilized in outward-
invaginated (convex-shaped) membranes such as filopodia (Figure 2.11A). When DAT 
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concentration is high, local membrane crowding by DAT molecules may induce outward 
bending of the membrane, thus initiating filopodia formation as shown in Figure 2.2. DAT 
mutants, in which mutations disrupt intramolecular interactions required to stabilize the OF 
conformation, or wt DAT with phosphorylated N-terminus, do not maintain a concave shape, and 
therefore have a lower propensity to occupy curved membranes and do not concentrate in 
filopodia. The OF conformer of wt DAT tends to accumulate in membrane regions with high 
curvature like filopodia and cell edges due to the convex shape of the OF conformer. AMPH 
shifts the equilibrium of DAT conformation towards an IF state and thus reduces DAT 
concentrations in filopodia. Non-functional DAT mutant R60A with disrupted OF conformation 
is not targeted to curved membranes. Binding of cocaine or zinc to R60A stabilizes its OF state 
and a convex shape, thus driving R60A to filopodia. 
Figure 2.11B shows an illustration of a monomer (green ribbons) and a dimer (orange 
and yellow ribbons) embedded into filopodia (Provided by Mary Cheng in Bahar lab), indicating 
that the oligomerization of DAT tends to generate more curvature than monomer. Therefore, the 
oligomerization of DAT may be an additional factor in targeting DAT to the membrane regions 
with high curvature, as it could increase the “concaveness” in the DAT multimer. However, it is 
currently impossible to test the role of oligomerization in DAT filopodia targeting because the 
mechanism of DAT oligomerization is unknown, and DAT mutants that cannot be oligomerized 
are unfolded and unable to traffic to the plasma membrane (Sorkina et al 2003).  
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Figure 2.11. Hypothetical model of the regulation of DAT concentration in curved membranes by its conformation. 
The increased number of filopodia in cells expressing high levels of YFP-HA-DAT is a 
surprising finding (Figure 2.2). This finding suggests that DAT may induce filopodia formation 
and/or maintain filopodia. It has been proposed that membrane bending by I-BAR domain 
proteins together with actin polymerization that regulated by Rho family small GTPases and I-
BAR domain protein binding partners is involved in the initiation of filopodia formation (section 
1.5). We propose that membrane bending induced by transmembrane proteins with concave 
shapes may contribute to the initiation of filopodia. Similar observation of the filopodia-induced 
activity of a transmembrane protein, lipoprotein receptor-related protein (LRP), was reported 
(Chazaud et al 2002). We propose that high local concentrations of concave-shaped DAT may 
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promote outward membrane bending, which would in turn facilitate the recruitment of I-BAR 
proteins and their binding partners to negatively-curved membranes, thus allowing stabilization 
of forming membrane protrusions by growing actin filaments. DAT overexpression does not 
significantly change the length of filopodia in heterologous expression system in our experiments 
(data not shown), consistent with the hypothetic role of DAT in initiation but not maintenance of 
filopodia. 
Certainly, targeting or filopodia-initiation capacity of DAT may also involve DAT 
interactions with actin-associated proteins or lipids enriched in filopodia. DAT and MyoX 
colocalize at the tips of filopodia, but MyoX knockdown does not fully diminish the ability of 
DAT to induce filopodia formation in heterologous expression system (Caltagarone et al 2015). 
Both DAT and MyoX can be detected in the growth cones of cultured dopaminergic neurons 
(Caltagarone et al 2015). Up to date, other filopodia-specific proteins has not been shown to 
interact with DAT. DAT interacts with phosphatidylinositol-4,5-bisphosphate (PIP2), a lipid that 
is important for the formation of filopodia (section 1.5). However, deletion of the putative PIP2 
binding site in the N-terminus of DAT (mutant ∆36 N-terminus) did not abolish the enrichment 
of DAT in filopodia (Sorkina et al 2009). Membrane cholesterol binds DAT and is proposed to 
stabilize DAT’s outward-facing conformation (Hong & Amara 2010, Penmatsa et al 2013). We 
have used methyl-β-cyclodextrin (MβCD) (5-10 mM, 5-20 min treatment) to deplete membrane 
cholesterol in HEK293 cells. The MβCD treatment did not affect the concentration of wt YFP-
HA-DAT to filopodia (data not shown), however, it may not eliminate cholesterol molecule that 
is bound to DAT while disrupting lipid rafts. In summary, MyoX may stabilize DAT localization 
in filopodia, but it is not necessary. Filopodial DAT interacts with lipids such as PIP2 and 
cholesterol. 
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The ability of proteins with domains that have intrinsic convex or concave shapes to 
sense high-curvature membrane regions, concentrate in these regions, or contribute to membrane 
bending is well established (Jarsch et al 2016). For example, IRSp53 and MIM (described in 
section 1.5) initiate membrane bending during the formation of filopodia. Potassium channel 
KvAP has been demonstrated to be enriched in membrane nanotubes formed from giant 
unilamellar vesicles in vitro (Aimon et al 2014). The chemoreceptor TlpA oligomers of Bacillus 
subtilis are localized to highly curved membranes and this localization is affected when the 
convex shape of the receptor is disrupted by mutations (Strahl et al 2015). Assembly of ATP 
synthase dimer rows shapes the highly curved mitochondrial cristae of yeast (Davies et al 2012). 
The regulation of DAT submembrane distribution by its conformational states and their 
transitions presented in this study gives the first example of the regulation of the localization of 
mammalian multi-membrane spanning proteins by membrane curvature. 
The concentration of DAT in dopaminergic neurons is difficult to quantify, and therefore, 
it is unclear whether endogenous DAT can promote membrane protrusions in neurons or it is 
simply concentrated in filopodia and other curved membranes. The width of mammalian 
filopodia is about 100-300 nm, which is similar to the width of axon shaft (Block et al 2015, 
Chéreau et al 2017). Based on our observations in cultured primary dopaminergic neurons using 
immunofluorescence microscopy, DAT is concentrated in axons, in particular, axonal 
varicosities, as compared to the somatodendritic region of the neuron (Block et al 2015). In 
cultured neurons, DAT is shown to be concentrated at the tips of filopodia-like protrusions along 
axons (Rao et al 2012). Although the multi-scale imaging of DAT knockout mice did not reveal 
any obvious morphological changes in dopaminergic neurons (Berlanga et al 2011), more 
detailed comparative imaging analysis of dopaminergic neurons in wt and DAT knockout mice 
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are necessary in order to determine whether DAT also plays a role in axonal growth, branching 
and synaptogenesis in developing dopaminergic neurons. 
 63 
3.0  EFFECTS OF PIP2 DEPLETION ON DAT LOCALIZATION AND 
ENDOCYTOSIS 
3.1 ABSTRACT 
Since DAT functions at the cell surface, endocytosis is a major regulator of DAT DA clearing 
activity. Other research groups and our laboratory have demonstrated that DAT is slowly 
constitutively endocytosed via clathrin-mediated endocytosis (CME) and clathrin-independent 
endocytosis (CIE) pathways, and that protein kinase C (PKC) activation results in accelerated 
clathrin-mediated endocytosis of DAT. Recently, it has been shown that phosphatidylinositol 
4,5-bisphosphate (PIP2), a phosphoinositide highly enriched in the plasma membrane, directly 
binds to the N-terminus of DAT through electrostatic interaction. The interaction of DAT with 
PIP2 was proposed to regulate DAT activity and density in the plasma membrane, possibly by 
stabilizing DAT in the plasma membrane. We have combined the approach of inducible, targeted 
depletion of PIP2 in the plasma membrane with a quantitative DAT endocytosis assay to directly 
examine the role of PIP2 in the regulation of DAT endocytosis. These experiments demonstrated 
that depletion of PIP2 did not affect DAT steady-state distribution in the cell, suggesting that 
DAT-PIP2 interaction does not play a significant role in DAT retention at the cell surface. By 
contrast, PIP2 depletion inhibited PKC-dependent DAT endocytosis, consistent with the 
predominant role of the clathrin pathway in this endocytosis. 
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3.2 INTRODUCTION 
Phosphatidylinositol 4,5-bisphosphate (PIP2) is a minor phospholipid that is highly enriched in 
the plasma membrane. PIP2 levels are controlled by kinases converting it from PI4P and 
dephophorylated by multiple PI5P phosphatases (Hammond et al 2012). PIP2 can be hydrolyzed 
by phospholipase C (PLC) to produce diacylglycerol (DAG) and inositol 1,4,5-trisphosphate 
(IP3). DAG stays on the plasma membrane to activate PKC, therefore initiating PKC-stimulated 
signaling cascades, while IP3 enters the cytoplasm to activate its receptors. PIP2 also acts as lipid 
binding partner to regulate the activity of membrane proteins such as the sodium-calcium 
exchanger (NCX1) and the ATP-sensitive KATP channel (Kir6.2/SUR2) (Suh & Hille 2005). 
Through direct binding, PIP2 promotes the membrane insertion of many transporters and ion 
channels (Huang 2007). PIP2 was shown to be necessary for recruitment of AP-2, epsin and 
dynamin to the plasma membrane, thus having an important role in initiating the assembly, 
stabilization and maturation of clathrin-coated pits and vesicles (Antonescu et al 2011). In 
addition, PIP2 regulates proteins involved in initiating actin filament assembly and reinforcing 
membrane cytoskeletal linkage, and dissociates barbed end and capping proteins to promote 
actin polymerization (Zhang et al 2012). Because many CIE pathways are mediated by actin 
cytoskeleton, these pathways are also PIP2-dependent.        
It has been proposed that PIP2 binds to amino acid residues 1-20 in the N-terminus of 
DAT through electrostatic interactions (Hamilton et al 2014). Mutation of both Lys3 and Lys5 to 
alanine disrupts DAT-PIP2 interaction, suggesting that the positive charge of the N-terminus is 
critical for DAT-PIP2 interaction. Using these mutations, it has been demonstrated that DAT-
PIP2 interaction is necessary for AMPH-induced reverse transport activity (efflux) of DAT 
(Hamilton et al 2014). Expression of the DAT K3A/K5A mutant in Drosophila dopamine 
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neurons does not affect locomotor activity but impairs AMPH-induced hyper-locomotion in vivo 
(Hamilton et al 2014). Computational modeling analysis predicts that PIP2 regulates the 
spontaneous inward opening of DAT, which results in the release of an sodium ion from the 
sodium binding site of DAT, facilitating the uptake of DA (Khelashvili et al 2015).   
Since PIP2 interacts with the N-terminus of DAT, which is important for 
retaining/protecting DAT from endocytosis (Sorkina et al 2009), it is logical to test whether the 
N-terminus interaction with PIP2 is important for stabilizing the surface level of DAT. In fact, it 
has been proposed that PIP2 depletion enhances DAT endocytosis and reduces DA uptake 
activity (Fagan et al 2015). However, the approach of PIP2 depletion used in the latter studies 
was not highly specific, therefore, long-term depletion of PIP2 may result in pleiotropic cellular 
changes that are difficult to interpret also, as PIP2 is involved in many signaling pathways. In the 
present study, we have optimized the combination of targeted, inducible depletion of PIP2 in the 
plasma membrane with quantitative measurement of DAT endocytosis to examine the role of 
PIP2 in regulating steady-state and PKC-stimulated traffic of DAT. 
3.3 MATERIALS AND METHODS 
3.3.1 Cell culture and transfections 
HEK293 cells (Invitrogen, #R70507) were grown in DMEM containing 10% FBS. The plasmid 
HA-DAT with the HA epitope inserted in EL2 of DAT was described previously (Sorkina et al 
2006). Lyn11-FRB (FKBP-rapamycin binding domain)-iRFP (Lyn11-FRB-iRFP), Lyn11-FRB-
CPF, mRFP-FKBP (FK506 binding protein)-INPP5E (inositol polyphosphate-5-phosphatase E) 
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(mRFP-FKBP-INPP5E), BFP-FKBP-INPP5E, GFP-tagged PH (Pleckstrin Homology) domain 
of phospholipase C δ (GFP-PH-PLCδ) and YFP-PH-PLCδ were kindly provided by Dr. G. 
Hammond (University of Pittsburgh, Pittsburgh, PA). The Effectene method (Qiagen, Valencia, 
PA) was used for plasmid transfections. Cells were plated on poly-D-lysine-coated glass 
coverslips one day after transfection and used for experiments on the next day. 
3.3.2 Endocytosis assay 
The schematic strategy of the endocytosis assay using Fab fragment secondary antibodies is 
shown in Figure 3.1. HEK293 cells transiently expressing HA-DAT were incubated with mouse 
anti-HA11 antibodies (1:1000) at 37 °C for 1-2 h. The cells were then stained with anti-mouse 
antigen-binding (Fab) fragment antibody conjugated with Cy3 (Fab-Cy3) (1:400) at RT for 10 
min (conditions of minimal DAT endocytosis), followed by treatment with rapamycin and/or the 
PKC activator phorbol 12-myristate 13-acetate (PMA) or vehicle in DMEM at 37 °C. Surface 
DAT with Fab-Cy3 may internalize, and some DAT localized to endosomes may recycle back to 
the plasma membrane. Cells were then incubated with an excess of anti-mouse Fab-Cy5 
antibodies (1:100) at RT for 10 min to label surface DAT. Cells were fixed with freshly prepared 
4% paraformaldehyde at RT for 15 min, and mounted in ProLong Gold (Invitrogen). 
 
 67 
 
Figure 3.1. Schematic strategy of endocytosis assay. 
3.3.3 Fluorescence microscopy and image analysis 
The coverslips were placed onto the stage of the spinning disk confocal imaging system 
controlled by SlideBook software (Intelligent Imaging Innovation, Denver, CO) as described in 
2.2.4. To obtain high-resolution 3D images of the cells, a z-stack of 10-20 confocal images at 
400 nm z-stepsize was acquired. 
To quantify the relative amount of Cy5 (surface DAT) and Cy3 (internalized DAT) 
fluorescence in images obtained in the endocytosis assay, background-subtracted 3D images 
were segmented using the minimal intensities of Cy5 and Cy3 as low thresholds to obtain Mask1 
and Mask2 corresponding to the surface and total DAT, respectively. The overlapping portions 
of Mask1 and Mask2 were used to generate Mask3 to measure Cy3-labeled surface DAT. Mask3 
was subtracted from Mask2 to obtain corrected Cy3-labeled internalized DAT in Mask4. The 
integrated voxel intensity of Mask1 (Cy5) and Mask4 (Cy3) (in arbitrary linear units of 
fluorescence intensity) were quantitated, and the ratio of Mask4 to Mask1 integrated intensities 
(Internalized/surface DAT) was calculated in each image.  
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3.3.4 Statistical analysis 
All data were analyzed using GraphPad Prism 6.0. Data normality of all data sets was confirmed 
using the D’Agostino-Pearson test. The statistical differences among each experimental groups 
were calculated using two-way ANOVA followed by Bonferroni’s multiple comparisons (Figure 
3.4B). F (1,36)=4.647, P=0.0379 (for the interaction of rapamycin treatment and PMA treatment 
in two-way ANOVA). Results are shown as mean ± S.E.M, n=10. *p<0.05, **p<0.01. 
3.4 RESULTS 
3.4.1 Rapid depletion of PIP2 in the plasma membrane 
Because PIP2 is involved in multiple essential cellular processes, continuous depletion of PIP2 
from the plasma membrane results in significant general toxicity. A rapamycin-inducible strategy 
of rapid and organelle-targeted depletion of PIP2 provides a controllable way to specifically 
reduce PIP2 level in the plasma membrane (PM) (Varnai et al 2006). PIP2 can be 
dephosphorylated to phosphatidylinositol 4-phosphate (PI4P) by inositol polyphosphate-5-
phosphatase E (INPP5E). In the method, schematically depicted in Figure 3.2, cells are 
transfected with two plasmids, in which: 1) INPP5E is fused to FK506 binding protein 
(FKBP12) and mRFP (monomeric red fluorescent protein) (or BFP, blue fluorescent protein ); 
and 2) a plasma membrane targeting sequence from Lyn tyrosine kinase (Lyn11) is fused to 
FKBP-rapamycin binding domain (FRB) and iRFP (near-infrared fluorescent protein) (or CFP, 
cyan fluorescent protein) (Hammond et al 2012). In addition, the localization of PIP2 is detected 
 69 
by fluorescent probes such as GFP (green fluorescent protein) (or YFP) fused to the Pleckstrin 
Homology (PH) domain of phospholipase C δ (PH-PLCδ) (Hammond et al 2014). As shown in 
Figure 3.3, before rapamycin treatment, FKBP-INPP5E locates in the cytosol and PH-PLCδ 
decorates the plasma membrane due to binding to PIP2. Rapamycin induces the 
heterodimerization of FRB and FKBP12. Therefore, upon rapamycin treatment, FKBP-INPP5E 
translocates to the plasma membrane and converts PIP2 to PI4P, resulting in the relocation of 
PH-PLCδ from the plasma membrane to the cytosol.  
 
Figure 3.2. Strategy of rapamycin-induced PIP2 depletion. 
To test the this new approach, Lyn11-FRB-iRFP, mRFP-FKBP-INPP5E and GFP-PH-
PLCδ were transiently co-expressed in HEK293 cells. Live cells were visualized by confocal 
microscopy before and after rapamycin (1μM) incubation for 5 min at RT through 488 nm 
(GFP), 561 nm (mRFP), and 640 nm (iRFP) filter channels. Representative images from one 
single z-plane are shown in Figure 3.3. The scale bars are 10 μm. After rapamycin treatment, a 
substantial amount of mRFP-FKBP-INPP5E translocated from the cytosol to the plasma 
membrane, whereas a bulk of GFP-PH-PLCδ translocated from the plasma membrane to the 
cytosol, indicating that PIP2 was depleted from the plasma membrane. The depletion (as 
measured by membrane-associated sensor protein) was typically not complete after 5 min 
 70 
rapamycin treatment, likely, because of insufficient mRFP-FKBP-INPP5E recruitment to the 
membrane. Incubations of 5-30 min with rapamycin resulted in a more efficient PIP2 depletion, 
though longer incubations caused visible general toxicity in some cells. 
 
Figure 3.3. Rapamycin-induced PIP2 depletion from the plasma membrane in HEK293 cells. 
3.4.2 Plasma membrane PIP2 depletion blocks PKC-stimulated DAT endocytosis 
Establishing experimental conditions of targeted PIP2 depletion allowed us to examine the role of 
PIP2 in constitutive and PKC-stimulated DAT endocytosis. We performed our endocytosis assay 
in HEK293 cells with the transient co-transfection of four plasmids: HA-DAT, Lyn11-FRB-CFP, 
BFP-FKBP-INPP5E and YFP-PH-PLCδ. After labeling surface HA-DAT with the HA11 
antibody and sequential incubation with Fab-Cy3 (see section 3.3.2), the cells were incubated 
with DMSO (vehicle control) or rapamycin (1 μM) for 5 min at RT. Cells were then incubated 
with PMA (1 μM) or DMSO for 30 min at 37°C in the same medium, followed by short 
exposure to Fab-Cy5 (10 min at RT) to label HA-DAT complexes remaining on the cell surface, 
and fixed. Images were acquired through 515 nm (YFP, green), 561 nm (Cy3, red) and 640 nm 
(Cy5, blue) filter channels. Cells with cytosolic YFP-PH-PLCδ were identified as cells with PIP2 
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depletion and used for quantitation of Cy3/Cy5 ratios. Representative images of single z-planes 
are shown in Figure 3.4A. The arrows point to examples of DAT endosomes (Cy3, no Cy5). The 
scale bars are10 μm.  
As shown in Figure 3.4A, a few vesicles containing internalized HA-DAT (labeled by 
Cy3 but not Cy5) were detected in vehicle treated cells (no PMA). The amount of endosomal 
HA-DAT was significantly increased upon PMA treatment. Cells in which most YFP-PH-PLCδ 
was translocated from the plasma membrane to the cytosol were selected for quantification of the 
extent of HA-DAT endocytosis. The quantitation of internalized/surface DAT ratios is shown in 
Figure 3.4B (n=10). It appears that PIP2 depletion does not affect the amount of endosomal 
(Cy3-labeled) HA-DAT in vehicle-treated cells, indicating that PIP2 depletion does not affect 
steady-state of internalized DAT. By contrast, PKC-stimulated endocytosis of HA-DAT was 
inhibited by PIP2 depletion, as evident by the reduced number of Cy3-labeled HA-DAT vesicles 
in the presence of rapamycin (Fig. 3,4A), which is confirmed by quantitation (Fig. 3.4B). These 
experiments demonstrated that PIP2 depletion inhibits PKC-stimulated but not constitutive DAT 
trafficking. 
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Figure 3.4. PIP2 depletion inhibits PKC-stimulated DAT endocytosis. 
3.5 DISCUSSION 
In this study, we have combined rapamycin-induced membrane PIP2 depletion and optimized 
endocytosis assay using Fab fragment antibodies, which are capable to enter live cells, to 
quantitatively study the role of PIP2 in constitutive versus PKC-stimulated DAT endocytosis. 
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This method required simultaneous high levels of co-expression four proteins. We have been 
able to achieve this only in HEK293 cells. 
The observation that PIP2 depletion blocked PKC-stimulated endocytosis of DAT in our 
experiments provides an important positive control to our approach. Indeed, it has been shown 
that PKC-induced DAT endocytosis is clathrin-dependent (Daniels & Amara 1999, Sorkina et al 
2005, Sorkina et al 2006). Thus, our experiments confirm this notion, and also confirm the role 
of PIP2 in CME using DAT as an endocytic cargo. Plasma membrane PIP2 depletion has been 
shown to result in significant loss of CCPs and disruption of CME (Zoncu et al 2007). In fact, in 
our control experiments, PIP2 depletion substantially inhibited endocytosis of transferrin-
TexasRed, a classical marker of CME (Hansen et al 1993) (data not shown).  
PIP2 depletion did not result in increased accumulation of DAT in endosomes in the 
absence of stimuli, suggesting that this depletion did not increase constitutive endocytosis or 
decreased constitutive recycling of DAT in HEK293 cells (Figure 3.4). This result is inconsistent 
with the report where Dr. Melikian and co-workers have proposed that PIP2 is involved in the 
retention of DAT at the cell surface (Fagan et al 2015). According to their model that PIP2 
depletion inactivates the kinase activated by Cdc42 kinase (Ack1), which maintains DAT surface 
level by preventing DAT endocytosis (Shen et al 2011, Wu et al 2015). Cdc42 activates Ack1, 
that negatively regulates basal DAT endocytic rate (Wu et al 2015).  
Our experiments also revealed no statistically significant decrease constitutive DAT 
endocytosis upon membrane PIP2 depletion, suggesting that blockade of clathrin-dependent 
endocytosis by membrane PIP2 depletion does not affect constitutive DAT endocytosis in 
HEK293 cells. It seems to be counteractive to our previous conclusion that both constitutive and 
PKC-stimulated DAT endocytosis are at least partially dependent on clathrin in PAE cells 
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(Sorkina et al 2005). The latter results were obtained using monensin treatment, which resulted 
in constitutive accumulation of internalized DAT in endosomes due to the blockade of DAT 
recycling. However, similar effect of monensin treatment was not statistically significant in 
HEK293 cells. Therefore, constitutive internalization rates could not be directly measured in 
these cells, because the Cy3/Cy5 ratio measured in HEK293 cells (Fig. 3.4B) is the sum of 
recycling and internalization rates.  
It has been suggested that constitutive DAT internalization is mediated by a dynamin-
independent and clathrin-independent endocytosis pathway in SK-N-MC cells using 
dynamin/clathrin inhibitors (Gabriel et al 2013). Notably, the clathrin inhibitor pitstop blocks 
both CME and CIE. It is possible that the mechanisms controlling constitutive DAT endocytosis 
are different in different cell types (Loder & Melikian 2003). There is a possibility that 
constitutive DAT endocytosis is not dependent on clathrin in HEK293 cells, or that the reduced 
clathrin-dependent DAT endocytosis is compensated by clathrin-independent DAT endocytosis 
induced by PIP2 depletion.  
Understanding the mechanisms controlling DAT trafficking in neurons is the most 
important problem when studying the role of PIP2 regulation in DAT endocytosis. However, 
targeted depletion of PIP2 is not feasible in dopaminergic neurons at this time. Our results in 
HEK293 cells indicate that PIP2 is not involved in the retention of DAT in the plasma 
membrane, whereas it is possible that PIP2 regulates DAT endocytosis. Interestingly, knockout of 
synaptojanin (PIP2 phosphatase) had strong effects on DAT localization in mouse brain (Cao et 
al 2017), suggesting that DAT is indeed regulated by PIP2 mediated trafficking. 
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4.0  IDENTIFICATION OF PROTEINS INTERACTING WITH DAT IN MOUSE 
STRIATUM 
4.1 ABSTRACT 
The function of DAT may be regulated by its interaction with other proteins. To identify DAT 
interacting proteins, we immunoprecipitated HA-DAT from synaptosomes isolated from mouse 
striatum and performed quantitative mass spectrometry proteomic analysis of 
immunoprecipitates. Differential mass-spectrometry (dMS) analysis revealed the specific co-
immunoprecipitation of several proteins with DAT, including previously identified DAT 
interactors and novel putative interactors. We focused our follow-up analysis on one of the 
putative DAT interactors, Gαo, the α subunit of Go heterotrimeric proteins, because it is coupled 
to the D2 auto-receptor (D2R), expressed in dopaminergic neurons and a known regulator of 
DAT. In subsequent experiments we demonstrated that Gαo is partially co-localized with DAT 
in primary cultured mesencephalic postnatal dopaminergic neurons. Reciprocal co-
immunoprecipitation followed by western blotting confirmed the interaction between DAT and 
Gαo in mouse brain striatum and HEK293 cells in which tagged DAT and Gαo were transiently 
expressed. These experiments revealed new DAT interactions, which may underlie novel 
mechanisms of DAT regulation by GPCR signaling.  
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4.2 INTRODUCTION 
As discussed in section 1.4, despite multiple attempts to define DAT interactome and its 
functional role, most reported interactions remain poorly characterized and not confirmed by 
more than one published study. With the development of truly quantitative methods of 
proteomics analysis of unlabeled samples, such as dMS (Wiener et al 2004), it has become 
possible to re-visit this research direction and perform careful analysis of proteins interacting 
with DAT in the mouse brain. This analysis is described below and points on the potential 
importance of DAT regulation by D2 receptors. 
Multiple studies indicate that DAT dynamics are regulated by D2 GPCR signaling. It has 
been demonstrated that activation of presynaptic D2R (the short form) increases DAT surface 
expression and function (Gulley & Zahniser 2003). D2R agonists enhance DAT uptake activity 
by increasing the surface expression of DAT in HEK cells and Xenopus laevis oocytes (Bolan et 
al 2007, Mayfield & Zahniser 2001). Conversely, knockout mice lacking presynaptic D2R 
exhibit decreased DAT uptake activity (Dickinson et al 1999). Similarly, treatment with D2R 
antagonist also results in decreased DA clearance rate (Dickinson et al 1999). The Gi/o inhibitor 
pertussis toxin (PTX) prevents the increase of DAT surface expression and its DA uptake 
activity that is induced by D2R activation (Bolan et al 2007, Mayfield & Zahniser 2001). The 
increase in DAT function by presynaptic D2R activation can be utilized to rescue decreased DA 
uptake in hypoinsulinemia (Sevak et al 2007). However, signal transduction mechanisms 
involved in D2R regulation of the DAT activity are unclear. 
D2R predominantly couples to Go proteins in the human central nervous system (Jiang et 
al 2001). Upon D2R activation, Gαo, the alpha subunit of Go proteins, is released from the 
heterotrimeric Go protein complex and binds to its downstream effectors. Gαo is widely 
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expressed in the CNS. Mice with Gαo knockout display multiple neural abnormalities (Jiang & 
Bajpayee 2009). Because we have identified Gαo-DAT interaction in mouse striatum, we 
hypothesize that Gαo directly interacts with DAT, and have begun to investigate the mechanism 
and functional role of this putative interaction. 
4.3 MATERIALS AND METHODS 
4.3.1 Reagents 
Antibodies were purchased from the following sources: monoclonal mouse anti-HA11 antibody 
was from Covance (Berkley, CA); monoclonal rat anti-DAT and polyclonal rabbit anti-Gαo 
antibodies were from EMD Millipore (Billerica, MA); rabbit anti-α-actinin antibody was from 
Cell Signaling Technology (Danvers, MA); donkey anti-mouse and anti-rabbit antibodies 
conjugated with Cy5 or Cy3 were from Jackson Immuno Research (West Grove, PA). Yellow 
fluorescent protein (YFP)- and HA-tagged human DAT (YFP-HA-DAT) was described 
previously (Sorkina et al 2009). Human Gαo sequence cloned into pcDNA 3.1+ vector was 
purchased from Invitrogen (Carlsbad, CA). Protein G-Sepharose was purchased from Invitrogen. 
Paraformaldehyde was purchased from Electron Microscopy Sciences (Hatfield, PA). Cell 
culture reagents were purchased from Invitrogen. All other chemicals were from Sigma-Aldrich 
(St. Louis, MO) unless otherwise specified. 
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4.3.2 Striatal synaptosome preparation and immunoprecipitation (IP) 
Twelve 8-week HA-DAT knock-in mice with hemagglutinin epitope inserted into the second 
loop of DAT (Rao et al 2012) were euthanized and decapitated. Brains were quickly removed 
and rinsed in ice-cold Gey’s balanced salt solution with 10 mM D-glucose. Striatal tissue was 
collected from the brain and placed in a glass homogenizer with ice-cold 5 mM HEPES (with 
0.32 M sucrose, pH 7.4, 1 ml for 45-50 mgs striatal tissue from one brain), followed by 
homogenization. The homogenate was centrifuged at 1,000 g for 10 min at 4 °C, and the 
resulting supernatant was transferred to a new tube and centrifuged at 12,500 g for 20 min at 4°C 
to isolate synaptosomes in the pellet.  
Synaptosomes were re-suspended in freshly prepared TGH lysis buffer (1% Triton X-
100, 10% glycerol, 25 mM HEPES, 1 mM EDTA, 1 mM EGTA, 1 mM sodium orthovanadate, 
10 mM sodium fluoride, 1 mM PMSF, 10 g/ml leupeptine, 10 g/ml aprotinin, 100 M 
iodacetamide) for 20 min at 4 °C. Lysed synaptosomes were centrifuged at 100,000 g for 20 min 
at 4 °C. The supernatants were incubated with 10 μg rat anti-DAT antibodies (6 tubes) or 10 μg 
rat IgG antibodies (6 tubes) for 3 h at 4 °C. The supernatants were further incubated with protein 
G-Sepharose for 1 h, and centrifuged at 12,500 g for 4 min at 4 °C to precipitate the protein G-
Sepharose. The protein G-Sepharose was washed with TGH buffer three times.  
Protein-G beads were boiled with 1x NuPAGE® LDS sample buffer containing 100 mM 
DTT and separated by SDS-PAGE for analysis by mass spectrometry. 
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4.3.3 Dopaminergic neuronal cultures 
Primary mesencephalic postnatal cultures were prepared from HA-DAT knock-in mice. The 
procedures were developed from our previous experiments (Rao et al 2011). Five to six mice 
pups aged P0-P3 were euthanized and decapitated. Brains were quickly removed and rinsed in 
ice-cold Gey’s balanced salt solution with freshly added 10 mM D-glucose. Coronal sections 
were taken and the mesencephalic dopamine region was dissected and placed in ice-cold Gey’s 
balanced salt solution with 10 mM D-glucose. After the dissection, midbrain tissue was placed in 
papain solution from the Papain Dissociation System Kit (Worthington, Lakewood, NJ). Tissue 
was dissociated following the kit protocol. Cells were suspended in feeding media made from 
Basal Medium Eagle with 4% fetal bovine solution (HyClone, Logan, UT), 1× B27 (Thermo 
Fisher Scientific, Pittsburgh, PA), 12.5 mM D-Glucose, 10 mM HEPES, 1 mM Sodium 
Pyruvate, 2 mM L-Glutamine, 40 Units/ml Penicillin and 100 μg/ml Streptomycin. About 
150,000 cells were plated onto 18 mm diameter glass coverslips coated with poly-D-lysine and 
laminin (neuVitro, Vancouver, WA) in 1 ml feeding media. Neurons were cultured in an 
incubator containing 5% CO2. 0.5 ml of feeding media was added to each coverslip to replace 
half the medium every other day. 
4.3.4 Fluorescence microscopy 
At days in vitro (DIV) 6-10, neurons were washed with CMPBS (DPBS plus 1 mM CaCl2, 0.5 
mM MgCl2 and 5 mM D-glucose) and fixed with freshly made 4% paraformaldehyde (PFA) in 
CMPBS for 15 min at room temperature. Neurons were permeabilized with 0.1% Triton X-100 
in CMPBS with 0.5% bovine serum albumin (BSA) for 5 min. Neurons were washed in CMPBS 
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with 0.5% BSA, and incubated with primary mouse anti-HA11 antibody (1:1000) and rabbit 
anti-Gαo antibody (1:500) for 1 h at room temperature, followed by 3X washes with CMPBS 
containing 0.5% BSA. Neurons were then incubated with secondary Cy3 anti-mouse and Cy5 
anti-rabbit antibodies for 1 h, followed by 3X washes with CMPBS containing 0.5% BSA. The 
coverslips were mounted in ProLong Gold (Invitrogen) and dried overnight for use.  
Neurons were imaged through 561 nm (Cy3) and 640 nm (Cy5) filter channels using our 
spinning disk confocal imaging system controlled by SlideBook software. A z-stack of 20 
confocal images at 400 nm z-step size was acquired under the 63× oil immersion objective lens 
with a 50-100 ms exposure time. 
4.3.5 Cell culture and transfections 
HEK293T cells were purchased from American Type Cell Culture Collections (Manassas, VA). 
Cells were grown in DMEM containing 10% FBS. The cells were transiently transfected with 
YFP-HA-DAT and Gαo using Effectene kits (Qiagen, Valencia, CA) following the kit protocol. 
Cells were plated in 100 mm dishes to grow, and used 2 days after transfection. 
4.3.6 Cross-linking enhanced immunoprecipitation (IP) and western blotting 
HEK293 cells were incubated with 1 mM dithiobis(succinimidyl propionate) (DSP, Thermo 
Fisher Scientific, Pittsburgh, PA) in HBSS buffer (with 1.26 mM CaCl2, 0.5 mM MgCl2, 0.4 mM 
MgSO4, 5 mM D-Glucose) for 10 min at 37 °C. Cross-linking was terminated with 20 mM Tris-
HCl, pH 7.0 at RT for 5 min (Zhang et al 2007). Cells were washed three times in ice-cold PBS, 
and lysed in freshly prepared TGH lysis buffer (1% Triton X-100, 10% glycerol, 25 mM HEPES, 
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1 mM EDTA, 1 mM EGTA, 1 mM sodium orthovanadate, 10 mM sodium fluoride, 1 mM 
PMSF, 10µg/ml leupeptine, 10 µg/ml aprotinin, 100 µM iodacetamide) for 20 min at 4 °C.  
For mouse brain immunoprecipitation, tissue was collected from the brain striatum and 
was lysed in freshly prepared TGH lysis buffer.  
Cell/tissue lysates were rotated at 4 °C for 1 h and centrifuged at 100,000 g for 20 min at 
4 °C. The supernatants were incubated with antibodies and kept rotating overnight at 4 °C. 
Protein G-Sepharose was added to the supernatants the following day. After a one-hour 
incubation, Protein G-Sepharose was precipitated and washed three times with TGH buffer (1% 
Triton X-100, 10% glycerol and 25 mM HEPES). For cells with DSP treatment, the protein G-
Sepharose was washed once with TGH buffer containing 500 mM sodium chloride, and then 
washed twice with regular TGH buffer. 
Ten-percent aliquots of cell/tissue lysates and immunoprecipitates were denatured in 
sample buffer at 95°C, resolved by 10% SDS-PAGE and transferred to nitrocellulose. Blots were 
probed with primary antibodies at 4 °C overnight. Secondary antibodies conjugated to far-red 
fluorescent dyes (IRDye-680 and 800) were applied the following day. Signal was detected using 
an Odyssey Li-COR system. 
4.4 RESULTS 
4.4.1 Gαo is a putative DAT interacting partner identified by MS 
To identify DAT interactors, we performed high-resolution MS analysis of the proteins pulled 
down from mouse striatum synaptosomes using antibodies against DAT or the same amount of 
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control non-specific antibodies. Dr. Xuemei Zeng from BioMS center performed the MS 
experiments. A total of 137 897 molecular features, including 5016 features for 1264 peptides 
from 363 proteins, were quantified using liquid chromatography mass spectrometry (LC-MS). 
Statistical analysis yielded seven putative DAT interactors, with at least half of their identified 
peptides being significantly more abundant in DAT IP samples than in control samples  
(Unpaired student’s t test p value < 0.05), including Gαo (Gao1), plasma membrane calcium-
transporting ATPase  (PMCA, Atp2b1), reticulon (Rtn1), excitatory amino acid transporter 
(EAAT, Slc1a2), mitochondrial glutamate carrier (GC, Slc25a22), synaptic vesicle glycoprotein 
2A (SV2A, Sv2a), and synaptogyrin-3 (Syngr3). The relative intensities of DAT (Slc6a3) and 
seven putative DAT interactors in IP samples pulled down using DAT antibodies (red) and non-
specific antibodies (green) are shown in Figure 4.1. 
Among seven putative DAT interacting proteins identified from MS analysis, the 
synaptic vesicle protein synaptogyrin-3 has been shown to interact with the recombinant peptide 
corresponding to the N-terminus of DAT, and when overexpressed, to up-regulate DAT activity 
(Egaña et al 2009). MS analysis is a primary method for searching for novel interactions and the 
results need to be further confirmed using other methods such as co-immunoprecipitation. SV2A 
is another synaptic vesicle protein that regulates neurotransmitter release, although its precise 
role in neurotransmitter release is unknown. Disrupted expression of SV2C leads to reduced DA 
release in dorsal striatum without changing DAT levels (Dunn et al 2017). PMCA and EAAT are 
presynaptic membrane transporters, and thus potentially capable of cis-interaction with DAT in 
the membrane. Reticulon predominantly resides in the ER and shapes the membrane curvature of 
the tubular ER (Voeltz et al 2006). GC catalyzes the entrance of glutamate into the mitochondrial 
matrix (LaNoue & Schoolwerth 1979). The interaction of these two proteins with DAT in intact 
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cells is unlikely because DAT is not present in the ER in axonal domains of neurons in the 
striatum and because DAT is not located in mitochondria.  
For the reasons described above, we focused on the role of DAT-Gαo interactions. As 
described in sections 1.1 and 4.2, Go proteins are coupled to D2 auto-receptors, and Go/i 
inhibitor PTX blocks the elevated DAT activity induced by D2R activation. Therefore, Gαo may 
play an important role in the regulation of DAT activity by D2R. Besides, Gαo has also been 
identified as a DAT interactor in our previous, qualitative MS analyses of DAT interacting 
proteins (data not shown).  
 
Figure 4.1. Relative abundance of putative DAT interactors (Xuemei Zeng, Yates lab). 
4.4.2 Validation of DAT and Gαo interaction 
To confirm the interaction between Gαo and DAT in the brain, we performed reciprocal co-IP 
experiments. The midbrain and striatum from one HA-DAT knock-in and wild-type mouse were 
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lysed and incubated with 10 μg HA11 antibody. Midbrain contains the cell body of dopaminergic 
neurons, while stratum contain the most axonal projections of dopaminergic neurons. IP and 
western blotting were carried out as described in section 4.3.6. Transferred proteins were probed 
with rat anti-DAT and rabbit anti-Gαo antibodies, followed by goat anti-rat and goat anti-rabbit 
secondary antibodies conjugated with far-red fluorescent 680 and 800 dyes, respectively. Gαo 
was immunoprecipitated with HA-DAT from the striatum of the HA-DAT knock-in mouse 
(fourth lanes from the left), but not that of the wild-type mouse (second lanes) (Figure 4.2A). 
The amounts of Gαo in lysates were similar, while the amount of Gαo in specific IP (the forth 
lane) is significantly larger than that in the second lane (non-specific IP). 
To test if DAT is co-immunoprecipitated with Gαo, the brains from two 8-week old wild-
type mice were dissected, and the midbrain and striatum tissue were lysed. Lysates were 
incubated with either rabbit anti-Gαo (2 μg) or non-specific rabbit IgG antibodies (2 μg). IP and 
western blotting were carried out similar to that of Figure 4.2A. DAT was co-
immunoprecipitated with Gαo but not with control IgG in the striatum (Figure 4.2B). We were 
not able to detect co-immunoprecipitation of DAT and Gαo in the midbrain because the amount 
of DAT in the midbrain is significantly lower than in the striatum. 
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Figure 4.2. DAT and Gαo interact with each other in mouse brain striatum. 
To examine the localization of Gαo in dopaminergic neurons, immunofluorescence (IF) 
staining was performed in primary mesencephalic neurons cultured for 6-10 days in vitro from 
P0-P3 HA-DAT knock-in mice. Neurons were fixed and stained as described in 4.3.4. Neurons 
were imaged through 561 nm (Cy3) and 640 nm (Cy5) filter channels. Both HA-DAT (red) and 
Gαo (green) are expressed in dopaminergic neuron axons and soma (Figure 4.3A) and dendrites 
(Figure 4.3B). White arrows point to colocalization of DAT and Gαo. The scale bars are 10 μm. 
As shown in Figure 4.3, Gαo was readily detected in dopaminergic neurons that were also 
positive for HA-DAT as well as in other neurons and glial cells in the preparation. In the axonal 
processes and somatodendritic compartments, Gαo and DAT displayed similar localization 
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patterns and were partially co-localized. Collectively, co-immunoprecipitation and IF 
experiments confirmed Gαo and DAT interaction in the perinatal brain. 
 
Figure 4.3. Both DAT and Gαo are expressed in the membrane of dopaminergic neurons. 
4.4.3 Interaction of recombinant DAT and Gαo in heterologous cells 
In order to further study the mechanisms of DAT-Gαo interaction, we performed 
immunoprecipitation experiments in HEK293 cells transfected with YFP-HA-DAT and Gαo. 
Cells transfected with only YFP-HA-DAT or Gαo were used as controls. At the third day after 
transfection, cells were lysed and incubated with the HA11 antibody. In another control group, 
cells expressing YFP-HA-DAT and Gαo were incubated with HA11 antibodies in the presence 
of the excess of the blocking HA11 peptide. To increase efficiency of co-precipitation and 
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reduce non-specific binding, we developed a method that uses reversible cross-linking with DSP 
to covalently trap interacting proteins before immunoprecipitation followed by washing of 
Protein G-Sepharose precipitates with high sodium chloride to minimize non-specific co-
precipitations. IP and western blotting were carried out as described in section 4.3.6. Transferred 
proteins were probed with primary rat anti-DAT, rabbit anti-Gαo and rabbit anti-α-actinin 
antibodies, followed by goat anti-rat and goat anti-rabbit secondary antibodies conjugated with 
far-red fluorescent 680 and 800 dyes, respectively.  
As shown in Figure 4.4, Gαo was immunoprecipitated by HA11 antibodies in HEK cells 
expressing both YFP-HA-DAT and Gαo (first lanes from the left). HA11 peptides competed out 
binding of YFP-HA-DAT to HA11 antibodies, thus minimizing co-immunoprecipitation of Gαo 
(second lanes). Gαo co-IP was also reduced in cells expressing only Gαo (fourth lanes) 
compared to the specific immunoprecipitates, despite essentially similar inputs. The experiments 
presented in Fig4.4 were repeated twice with the similar outcomes. These data demonstrate that 
recombinant DAT and Gαo interact in HEK293 cells. 
 
Figure 4.4. Gαo binds to DAT in HEK293 cells. 
To determine what part of the DAT molecule is involved in the Gαo interaction, we 
performed immunoprecipitation experiments in HEK293 cells in which Gαo was co-expressed 
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with wt YFP-HA-DAT or its mutants. YFP-HA-DAT with the deletion of the N-terminal amino 
acids 1-65 (YFP-HA-DAT ΔNT) caused a marked reduction in Gαo co-IP (Figure 4.5).  The 
effects of DAT N-terminal deletion on DAT-Gαo interaction have been examined three times, 
and representative data are shown in Figure 4.5. HEK293 cells were transfected with Gαo and 
YFP-HA-DAT wt or YFP-HA-DAT ΔNT. After culturing for 3 days, cells were lysed and 
immunoprecipitated by mouse anti-HA11 antibody. In the first lanes, HA11 peptide was added 
as a control. IP and western blotting were carried out as described in section 4.3.6. Transferred 
proteins were probed with primary rabbit anti-Gαo and rabbit anti-α-actinin antibodies, followed 
by goat anti-rabbit secondary antibody conjugated with far-red fluorescent 800 dye. After the UV 
inactivation fluorescent dyes, transferred proteins were then probed with primary mouse anti-
HA11 antibody, followed by goat anti-mouse secondary antibody conjugated with far-red 
fluorescent 800 dye.  
As shown in Figure 4.5, the HA11 peptide eliminated YFP-HA-DAT and Gαo signals 
(first lanes). The amount of Gαo co-immunoprecipitated with wt DAT (second lanes) is 
significantly higher than the amount in control IPs (third lanes). The Gαo bands in the lysates 
part are similar, while the Gαo IP band in the third lane is less bright than in the second lane, 
suggesting that deletion of DAT N-terminus partially inhibits DAT-Gαo interaction. Other 
mutants (YFP-HA-DAT with partially deleted N-terminus, YFP-HA-DAT with C-terminus 
deletion, and EGFR-linked DAT C-terminus) did not show the reduction in Gαo binding (data 
not shown). This analysis is highly preliminary and more experiments are necessary to define the 
mechanisms of DAT-Goa interaction. However, these co-IP experiments further confirm that the 
interaction between DAT and Gαo is likely direct, and that the N-terminal tail may be involved. 
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Figure 4.5. The N-terminus of DAT is involved in interaction with Gαo. 
4.5 DISCUSSION 
In this study we performed MS analysis of the proteins co-immunoprecipitated with DAT from 
striatal synaptosomes. The identification of synaptogyrin-3 in DAT immunoprecipitates validates 
our analysis as DAT:synaptogyrin-3 interaction has been previously reported by the Torres group 
(Egaña et al 2009). On the other hand, detection of mitochondrial glutamate carrier (GC, 
Slc25a22), which is a intramitochondrial transporter and cannot physically associate with DAT 
in intact cells, as a specific (P<0.05) DAT interactor suggests that the results of MS interactome 
analysis must be carefully validated using alternative methods (Figure 4.1). Certainly, co-
immunopreciptation, such as with Slc22A or reticulon, may be due to the interaction of DAT 
with these proteins after solubilization rather than in intact cells.  
Lack of comprehensive follow-up studies could be responsible for an inconsistent 
literature on DAT interactome. For example, interaction of DAT with HIC5 and RIN1 was 
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demonstrated only in single studies (Carneiro et al 2002, Navaroli et al 2011). The mechanisms 
of these interactions have not been characterized, e.g. sequence motifs in DAT have not been 
mapped, and there were no follow-up structure-function studies. Likewise, our laboratory 
demonstrated the role of NEDD4-2 in DAT ubiquitination in several studies (Sorkina et al 2006, 
Vina-Vilaseca & Sorkin 2010) but direct interaction between NEDD4-2 and DAT and its 
mechanism in regulating DAT ubiquitination have not been elucidated. 
We focused on a newly identified DAT interactor, Gαo, given the potential functional 
importance of this interaction. Gαo is known to be expressed in the CNS and is coupled to 
GPCRs expressed in DA neurons (Jiang & Bajpayee 2009). In dopaminergic neurons, dopamine 
D2 auto-receptors (D2SRs) are coupled to Go proteins. Previously published studies provide a 
strong rationale for focusing on the interaction. It has been demonstrated that the activation of 
D2 auto-receptor modulates the surface expression and function of DAT (Mayfield & Zahniser 
2001). DA treatment of Xenopus laevis oocytes expressing both DAT and D2SR up-regulates the 
surface expression and DA uptake activity of DAT. The increased DAT uptake activity upon 
D2SR activation is indeed blocked by PTX treatment in Xenopus oocytes. The PTX ADP-
ribosyltransferase ADP-ribosylates Gαo/i, resulting in the Go/i proteins being uncoupled from 
the associated receptors such as D2R (Mangmool & Kurose 2011). D2 agonist quinpirole rapidly 
increases DAT surface expression in HEK293/EM4 cells expressing both D2SR and DAT, and 
this effect is also blocked by PTX, again suggesting that the up-regulation of DAT function 
through D2SR activation is dependent on the activation of Gαo/i (Bolan et al 2007). The PTX-
sensitive up-regulated effect of D2SR activation on DAT has also been demonstrated in striatal 
synaptosomes (Thompson & Certain 2005). Although D2R has been shown to couple to both 
 91 
Gαo and Gαi proteins in heterologous cells (Gazi et al 2003), studies in Gαo-deficient mice 
suggest that most D2 receptors are predominantly coupled to Gαo in the CNS (Jiang et al 2001).  
In this study, we confirmed the interaction between DAT and Gαo in mouse brain 
striatum through reciprocal co-immunoprecipitation (Figure 4.2). Immunofluorescence staining 
of cultured primary mouse dopaminergic neurons showed that both DAT and Gαo were 
expressed in the membrane of dopaminergic neurons (Figure 4.3).  We also observed the co-
immunoprecipitation of overexpressed recombinant Gαo and YFP-HA-DAT in HEK293 cells 
(that express negligible levels of endogenous Gαo) with the help of DSP-mediated crosslinking 
(Figure 4.4). The mutant of YFP-HA-DAT with deleted N-terminus co-immunporecipitated less 
amount of Gαo than wild-type YFP-HA-DAT, indicating that the N-terminus of DAT may be 
involved in DAT-Gαo interaction (Figure 4.5).  
The main known function of active Gα subunits is to activate or inhibit the activity of 
adenylyl cyclase, thus regulating the cellular level of cAMP. Besides modulating adenylyl 
cyclase, active Gα subunits may bind to and regulate the activity of calcium, potassium, and 
sodium channels independent of cAMP level changes (Jiang & Bajpayee 2009). The detailed 
mechanisms for these Gαo effects have not been fully elucidated. However, there is direct 
physical interaction between Gαo and the α subunit of voltage-gated sodium channels, 
suggesting that Gαo may regulate the activity of downstream effectors through direct interaction 
(Anis et al 1999). Therefore, we hypothesize that the increase in DAT activity induced by D2SR 
activation in dopaminergic neurons can be mediated by direct Gαo interaction with DAT, and 
that DAT is a novel example of Goa effectors. Of note, it has also been shown that D2R directly 
binds to the N-terminus of DAT (Lee et al 2007). The co-expression of DAT and D2R results in 
increased DAT surface expression and activity, which is independent of the activation of D2R, 
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indicating that the direct DAT-D2R interaction may regulate DAT trafficking. However, D2R 
was not detected in our DAT immunoprecipitation experiments (data not shown). Therefore, 
whether DAT-D2R complex exists and whether such complex is important for regulation of 
DAT localization and activity remains to be further investigated.   
Dr. Torres and co-workers have demonstrated that Gβγ subunits directly interact with 
DAT and down-regulate the activity of DAT in both heterologous cells and brain tissue (Garcia-
Olivares et al 2013). It is possible that a Gβγ-induced decrease in DAT activity occurs upon the 
activation of GPCRs other than D2SR. Of note, Gβγ subunits have not been detected by MS or 
western blotting in our DAT immunoprecipitation experiments.  
Based on the previously demonstrated regulation of DAT by D2SR, and our 
demonstration of the physical interaction between DAT and Gαo, we propose a hypothetical 
model for Gαo mediated regulation of DAT activity by D2R (Figure 4.6). DA is released upon 
the fusion of DA vesicles with the presynaptic cell surface membrane. The binding of DA 
activates presynaptic D2 auto-receptors (D2SR). Gαo and Gβγ subunits are then released from 
heterotrimeric Go proteins that bound to D2SR. Gαo binds to DAT N-terminus that is important 
for maintaining surface DAT level by preventing constitutive endocytosis of DAT (Sorkina et al 
2009). Gαo binding to the N-terminus of DAT may be part of this retention mechanism, thus 
ensuring increased surface DAT levels and/or increased DAT uptake activity. Gβγ subunits may 
bind DAT and inhibit DAT activity, but this effect would be compensated by the function of 
Gαo. PTX treatment prevents DAT-Gαo interaction when D2SR is activated through uncoupling 
the D2SRs and Go proteins.  Certainly, this model is highly speculative and all events proposed 
in Figure 4.6 must be tested experimentally in dopaminergic neuronal models.   
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Figure 4.6. Hypothetical model for Go protein mediated regulation of DAT by D2R. 
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5.0  DISSERTATION SUMMARY 
5.1 OVERALL DISCUSSION AND CONCLUSIONS  
The overall goal of the dissertation is to further understand the mechanisms regulating DAT 
subcellular localization and trafficking. The research has been performed in three directions.  
The first project dealing with defining the mechanisms of filopodia targeting of DAT was 
the main focus of my thesis. These data described in Chapter 2 and two publications 
(Caltagarone et al 2015, Ma et al 2017) demonstrated for the first time that DAT molecule 
conformation is an important regulator of its subcellular localization. Although most mechanistic 
approaches to extend these studies in dopaminergic neurons have not been technically feasible, 
these studies provide a hypothetical model for the role of DAT conformation in the mechanisms 
responsible for DAT targeting to axonal domains of dopaminergic neurons.  
The second and third directions were highly exploratory. In the PIP2 project (chapter 3), 
we for the first time directly and specifically tested the role of PIP2 in DAT localization and 
trafficking. We developed a new approach where we combined the controllable membrane PIP2 
depletion and a modified endocytosis assay using Fab fragment antibodies to study the effects of 
PIP2 depletion and DAT trafficking. We have demonstrated that PIP2 depletion blocks PKC-
stimulated clathrin-dependent DAT endocytosis but does not change the steady-state of 
internalized DAT. PIP2 is essential for the formation of filopodia, as it provides a stage area for 
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the accumulation of filopodia assembly proteins such as IRSp53, MIM, profilin, and Ena/VASP. 
During our observation of rapamycin-induced membrane PIP2 depletion in HEK293 cells 
expressing YFP-HA-DAT, short-term membrane PIP2 depletion (5 min) did not affect the 
number of filopodia with YFP-HA-DAT, while long-term membrane PIP2 depletion (30 min) 
reduced the number of filopodia in HEK293 cells, resulting in many round cells (data not 
shown). Therefore, we propose that PIP2 is also important for the maintenance of filopodia 
enriched with DAT. The interaction between DAT and PIP2 may also play a role in DAT-
induced/facilitated filopodia formation. However, since long-term global membrane PIP2 
depletion eliminates the formation of all filopodia, it is hard to test the role of DAT-PIP2 
interaction in DAT-induced filopodia formation. 
In our proteomics experiments, we identified a novel interactor of DAT, Gαo. The MS 
analysis also confirmed the interaction between DAT and synaptogyrin-3, which has been shown 
by other research groups (Egaña et al 2009). These findings expand the knowledge of the DAT 
interactome. The expression of Gαo in the tips of the neurites of PC12 cells is increased after 
NGF treatment, indicating that Gαo may be involved in the extension of neurites during NGF-
induced differentiation (Andreopoulos et al 1995). This observation, together with the fact that 
DAT is localized to filopodia, suggests that DAT-Gαo interaction may appear in the 
neurites/growth cones neurons. The active Gαo subunits in the growth cones of dopaminergic 
neurons may be resulted from the activation of presynaptic D2 auto-receptor (D2SR).  
DAT-Gαo interaction may be required for the elevated DAT uptake activity induced by 
D2SR activation. So far, it is generally believed that D2SR activation increases the activity of 
DAT through stabilizing the surface expression of DAT (Bolan et al 2007, Mayfield & Zahniser 
2001). Therefore, we propose that DAT-Gαo interaction stabilizes the expression of DAT in the 
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membrane and protects DAT from endocytosis that may be caused by drugs of abuse and other 
pathophysiological conditions. Since that OF conformation helps to stabilize the localization of 
DAT in filopodia, where a large fraction of DAT is immobile (Rao et al 2012), this conformation 
may also protect DAT from endocytosis.  
While these three research projects were carried out as independent directions, 
experimental findings indicate that the three processes, filopodial targeting of DAT, the role of 
PIP2 in DAT trafficking and interaction between DAT and Gαo, may all be interconnected and 
involved in the regulation of DAT biology in neurons. Our hypothetical model of DAT 
regulation by the three above processes is summarized in Figure 5.1. In dopaminergic neurons, 
DAT is expressed in the plasma membrane of the cell body and axons. DAT undergoes 
constitutive endocytosis mostly in the cell body and only a little in the axon terminal. DAT is 
associated with PIP2 in the plasma membrane. The interaction between DAT and PIP2 may be 
involved in the filopodia formation that requires PIP2. DAT-PIP2 interaction may also regulate 
DAT trafficking in the cell body of dopaminergic neurons. DAT colocalizes with MyoX, which 
is also important for the formation of filopodia. The role of DAT in the tips of the filopodia of 
the growth cones needs to be understood. However, we have demonstrated that the mechanism 
for DAT entering filopodia is probably the intrinsic outward-facing conformation, which is 
independent of MyoX or the DAT-PIP2 interaction. It is possible that the DAT-Gαo interaction 
occurs in the tips of filopodia, as there is evidence that Gαo functions in the development of 
neurites/growth cones (Andreopoulos et al 1995). We propose that the main function of the 
DAT-Gαo interaction is to mediate elevated DAT surface expression level induced by the 
activation of D2SR in the presynaptic area. The coupling of D2SR and Go proteins can be 
disrupted by PTX, resulting in no effects of D2SR activation on DAT. The DAT-Gαo interaction 
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may stabilize DAT surface level and prevent DAT from endocytosisThe localization of DAT in 
filopodia can be regulated by the OF conformation and DAT-PIP2 interaction, and the DAT-Gαo 
interaction may also appear in filopodia. 
 
Figure 5.1. The schematic review of the dissertation. 
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5.2 FUTURE RESEARCH DIRECTIONS 
5.2.1 The role of the OF conformation in the distribution of DAT in the cell membrane 
In live-cell studies, it is very difficult to rule out all possible alternative or additional mechanisms 
for the targeting of DAT to filopodia, and in vitro biochemical studies must be performed to fully 
test our hypotheses. Membrane tube pulling method using giant plasma membrane vesicles 
(GPMVs) is a recently developed method to study the distribution of transmembrane proteins in 
curved membranes without interference of other cellular processes and cytoskeletal interactions 
(Aimon et al 2014). We will generate GPMVs from cells expressing YFP-DAT and its mutants 
with different conformations, and pull membrane tubes from the GPMVs. The GPMVs with 
membrane pulling can be imaged using our sensitive confocal microscope. If wt YFP-DAT but 
not R60A and W63A mutants are concentrated in the tubule domain of GPMVs, it supports our 
hypothesis that the localization of DAT in filopodia is driven by the intrinsic molecular 
conformation. If the results of in vitro experiments demonstrate that DAT is not accumulate in 
the membrane pulling of the GPMVs, we will continue our proteomics efforts in identifying 
DAT interactions that might be responsible for its accumulation in filopodia. 
The DAT mutation W84L has been proposed to be stabilized in the OF conformation 
(Jones et al 2012). This mutant can be compared to the W63A mutant, which exhibits the IF 
conformation, in future experiments to examine the regulatory role the OF conformation in DAT 
localization. We will express YFP-HA-W84L in HEK cells and test if the localization of this 
mutant in filopodia can be affected by AMPH treatment. AMPH treatment disrupts the OF 
conformation of wt DAT. If AMPH treatment does not reduce the concentration of YFP-HA-
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W84L in filopodia, it means that the OF conformation of these mutants cannot be disrupted by 
AMPH, further suggesting the importance of OF conformation in DAT filopodia localization.  
Further, we will also express the wt YFP-HA-DAT and the W84L, W63A mutants in 
cultured dopaminergic neurons derived from DAT KO mouse. We will use the approach of 
adeno-associated virus (AAV)-mediated delivery of the constructs under the tyrosine 
hydroxylase (TH) promoter into primary cultures of dopaminergic neurons. We will compare 
localization of wt and mutant DAT between axonal and somatodendritic domains to test our 
hypothesis that the OF state is important for DAT enrichment in axons. The morphology of 
dopaminergic neurons expressing wt DAT and the mutants will be also quantitatively analyzed. 
If the dopaminergic neurons expressing the W84L mutant demonstrate elevated numbers of 
filopodia and/or synapses, and/or enhanced axonal branching than those neurons expressing wt 
YFP-HA-DAT or the W63A mutant, this will suggest that DAT in its OF state may be directly 
involved in the development of dopaminergic neurons and their morphological organization.  
5.2.2 The mechanism of DAT trafficking upon PIP2 depletion  
One caveat of PIP2 depletion approach is that the depletion of total membrane PIP2 affects a 
multitude of DAT-related and unrelated processes. Therefore, I suggest developing a new 
approach. We will generate a chimeric protein in which the FRB construct is inserted before the 
N-terminus of HA-DAT (FRB-HA-DAT). This protein will be co-expressed with BFP-FKBP-
INPP5E and YFP-PH-PLC in HEK293 cells. The idea is that rapamycin-induced recruitment of 
the phosphatase to DAT will deplete PIP2 locally, in the proximity of DAT. We will then test the 
effect of rapamycin-induced local membrane PIP2 depletion on DAT localization and 
endocytosis. The specific deletion of membrane PIP2 near DAT as oppose to global PIP2 
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depletion will help to distinguish the specific role of PIP2 in DAT trafficking from the role of 
PIP2 in general trafficking processes. Cargo-specific targeting of PIP2 phosphatases has not been 
performed, and this project is expected to require considerable troubleshooting. If the local 
depletion of membrane PIP2 increases or decreases the internalized/surface ratio of DAT, it 
means that PIP2 regulates DAT internalization, endocytic trafficking, or recycling.  
5.2.3 The role of Gαo in regulating DAT function 
To reveal the function of the DAT-Gαo interaction, we will firstly identify Gαo binding motif in 
DAT and generate corresponding mutants. YFP-HA-DAT or its mutants incapable of binding 
Goa and CFP-Gαo will be co-expressed in HEK293 cells. Fluorescence-activated cell sorting 
(FACS) analysis will be used to collect cells expressing both YFP-HA-DAT and CFP-Gαo, 
followed by biotinylation and DA uptake assay. If the cells expressing both YFP-HA-DAT and 
CFP-Gαo exhibit more surface DAT and DA uptake activity in the assays than cells that express 
YFP-HA-DAT and control CFP, it suggests that the DAT-Gαo interaction increases DAT surface 
expression and activity in HEK293 cells. The direct physical interaction between DAT and Gαo 
will be confirmed using co-immunoprecipitation experiments. 
We will also examine the role of Gαo in regulating DAT function in dopaminergic 
neurons. We will develop the approach of adeno-associated virus (AAV)-mediated delivery of 
Gαo shRNA and GFP expressed under the TH promoter into dopaminergic neurons. GFP 
positive dopaminergic neurons (with Gαo knockdown) will be evaluated for endocytosis assay 
and single-cell substrate uptake assay uisng 4-(4-(dimethylamino)steryl)-N-methylpyridinium 
(ASP+) as described in (Inyushin et al 2013). ASP+ is a fluorescent substrate of DAT that can be 
used to test the uptake activity of DAT using quantitative confocal microscopy. If there is more 
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DAT endocytosis and less ASP+ uptake in dopaminergic neurons with Gαo knockdown, it would 
suggest that Gαo helps to stabilize DAT surface expression and reduce DAT endocytosis. Since 
active Gαo inhibits adenylyl cyclase, thus inhibiting the production of cAMP from ATP, we will 
also use adenylyl cyclase inhibitor to reduce cAMP level in dopaminergic neurons with Gαo 
knockdown. If the adenylyl cyclase inhibitor cannot rescue the effects of Gαo knockdown on 
DAT endocytosis and activity, it suggests that the capacity of Gαo to inhibit adenylyl cyclase is 
not involved in Gαo-regulated DAT function, which is consistent with our hypothesis that Gαo 
regulates DAT function through direct physical interaction.  
In the future, we will also generate HA-DAT knock-in mice with Gαo knockout by 
crossing Gαo knockout mice with the HA-DAT knock-in mice in our laboratory. Therefore, we 
will be able to perform DAT endocytosis assay in the cultured primary dopaminergic neurons 
prepared from these mice. If the internalized/surface ratio of DAT in the neurons with Gαo 
knockout is higher than that of the control neurons, it means that the expression of Gαo reduces 
constitutive DAT endocytosis. The adenylyl cyclase inhibitor will also be used to examine if the 
role of Gαo in regulating DAT endocytosis is dependent on cAMP changes. We will also test if 
Gαo knockout increase surface DAT level using biotinylation in brain slices. If mice with Gαo 
knockout exhibit increased surface DAT level compared to the control mice, it supports our 
hypothesis that Gαo stabilizes surface DAT expression.  
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